Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	RALGDS TRIO ARHGAP23 RGL3 SH3BP1 OBSCN RTKN ARHGEF17 FARP1 DENND4B EPS8L3 ARHGAP33 ARAP1 AGAP2	4.26e-05	507	155	14	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	RALGDS TRIO ARHGAP23 RGL3 SH3BP1 OBSCN RTKN ARHGEF17 FARP1 DENND4B EPS8L3 ARHGAP33 ARAP1 AGAP2	4.26e-05	507	155	14	GO:0030695
GeneOntologyMolecularFunction	protein serine kinase activity	TRIO PSKH1 SPEG OBSCN BRSK2 TESK1 PRKCG PKN1 WNK2 PKN3 MAST3	1.29e-04	363	155	11	GO:0106310
GeneOntologyMolecularFunction	protein serine/threonine kinase activity	TRIO PSKH1 SPEG TGFBR3L OBSCN BRSK2 TESK1 PRKCG PKN1 WNK2 PKN3 MAST3	1.94e-04	446	155	12	GO:0004674
GeneOntologyMolecularFunction	diacylglycerol-dependent serine/threonine kinase activity	PRKCG PKN1 PKN3	2.39e-04	16	155	3	GO:0004697
GeneOntologyMolecularFunction	guanyl-nucleotide exchange factor activity	RALGDS TRIO RGL3 OBSCN ARHGEF17 FARP1 DENND4B EPS8L3	4.55e-04	231	155	8	GO:0005085
GeneOntologyBiologicalProcess	small GTPase-mediated signal transduction	RALGDS TRIO ARHGAP23 RGL3 SH3BP1 OBSCN DOK2 RTKN ARHGEF17 ITPKB HEG1 CSF1 FARP1 DENND4B EPS8L3 ARHGAP33 ARAP1 DNM2	1.42e-07	538	156	18	GO:0007264
GeneOntologyBiologicalProcess	regulation of small GTPase mediated signal transduction	TRIO ARHGAP23 SH3BP1 OBSCN ARHGEF17 ITPKB HEG1 CSF1 DENND4B EPS8L3 ARAP1 DNM2	9.06e-06	333	156	12	GO:0051056
GeneOntologyBiologicalProcess	substrate adhesion-dependent cell spreading	FNDC3B TRIOBP SRCIN1 TESK1 RADIL MICALL2 DNM2	1.93e-05	109	156	7	GO:0034446
GeneOntologyCellularComponent	synaptic membrane	SHANK1 CACNA1C SUSD4 NLGN4Y LRFN3 BCAN GRIN2D FCHO2 SLC12A5 FARP1 SLC6A5 PRKCG TMEM108 SCRIB DNM2	3.00e-05	583	155	15	GO:0097060
GeneOntologyCellularComponent	glutamatergic synapse	SHANK1 VGF CACNA1C AMPH TRIO NLGN4Y LRFN3 ZDHHC5 BCAN SRCIN1 GRIN2D PPFIA3 FARP1 TMEM108 SCRIB ARHGAP33 DNM2 AGAP2	3.69e-05	817	155	18	GO:0098978
GeneOntologyCellularComponent	postsynaptic membrane	SHANK1 CACNA1C SUSD4 NLGN4Y LRFN3 GRIN2D SLC12A5 FARP1 TMEM108 SCRIB DNM2	2.25e-04	405	155	11	GO:0045211
GeneOntologyCellularComponent	lamellipodium	SH3BP1 APBB2 SRCIN1 TESK1 PABPC1 SCRIB APBB1IP DNM2	3.27e-04	230	155	8	GO:0030027
GeneOntologyCellularComponent	postsynaptic specialization	SHANK1 CACNA1C NLGN4Y LRFN3 ZDHHC5 SRCIN1 GRIN2D SLC12A5 PRKCG TMEM108 SCRIB DNM2	3.82e-04	503	155	12	GO:0099572
GeneOntologyCellularComponent	postsynapse	SHANK1 CACNA1C SUSD4 TRIO NLGN4Y LRFN3 ZDHHC5 SRCIN1 GRIN2D SLC12A5 FARP1 PRKCG TMEM108 PLCB3 SCRIB ARHGAP33 DNM2 AGAP2	5.59e-04	1018	155	18	GO:0098794
GeneOntologyCellularComponent	dendrite	SHANK1 CACNA1C NLGN4Y LRFN3 ZDHHC5 NTSR2 BCAN SRCIN1 PABPC1 SLC12A5 FARP1 PRKCG TMEM108 ARHGAP33 AGAP2 KIF1C	6.54e-04	858	155	16	GO:0030425
GeneOntologyCellularComponent	dendritic tree	SHANK1 CACNA1C NLGN4Y LRFN3 ZDHHC5 NTSR2 BCAN SRCIN1 PABPC1 SLC12A5 FARP1 PRKCG TMEM108 ARHGAP33 AGAP2 KIF1C	6.70e-04	860	155	16	GO:0097447
GeneOntologyCellularComponent	postsynaptic specialization membrane	CACNA1C NLGN4Y LRFN3 GRIN2D SLC12A5 TMEM108 SCRIB	7.68e-04	201	155	7	GO:0099634
GeneOntologyCellularComponent	postsynaptic density membrane	CACNA1C NLGN4Y LRFN3 GRIN2D TMEM108 SCRIB	1.14e-03	157	155	6	GO:0098839
GeneOntologyCellularComponent	cell leading edge	AMPH SH3BP1 APBB2 SRCIN1 TESK1 PABPC1 SLC12A5 EPS8L3 SCRIB APBB1IP DNM2	1.29e-03	500	155	11	GO:0031252
Domain	PH_dom-like	TRIO ARHGAP23 OBSCN PLEKHA4 APBB2 TRIOBP DOK2 RTKN ARHGEF17 SHC2 FARP1 PLCH2 PLCB3 TNS4 EPS8L3 APBB1IP ARAP1 DNM2 AGAP2	1.21e-09	426	148	19	IPR011993
Domain	-	TRIO ARHGAP23 OBSCN PLEKHA4 APBB2 TRIOBP DOK2 RTKN ARHGEF17 SHC2 FARP1 PLCH2 PLCB3 TNS4 APBB1IP ARAP1 DNM2 AGAP2	2.08e-09	391	148	18	2.30.29.30
Domain	PH	TRIO OBSCN PLEKHA4 TRIOBP DOK2 RTKN FARP1 PLCH2 APBB1IP ARAP1 DNM2 AGAP2	2.91e-07	229	148	12	PF00169
Domain	PH	TRIO ARHGAP23 OBSCN PLEKHA4 TRIOBP DOK2 RTKN FARP1 PLCH2 APBB1IP ARAP1 DNM2 AGAP2	3.39e-07	278	148	13	SM00233
Domain	PH_DOMAIN	TRIO ARHGAP23 OBSCN PLEKHA4 TRIOBP DOK2 RTKN FARP1 PLCH2 APBB1IP ARAP1 DNM2 AGAP2	3.53e-07	279	148	13	PS50003
Domain	PH_domain	TRIO ARHGAP23 OBSCN PLEKHA4 TRIOBP DOK2 RTKN FARP1 PLCH2 APBB1IP ARAP1 DNM2 AGAP2	3.68e-07	280	148	13	IPR001849
Domain	C2	ITCH CPNE5 SYT15B MCTP1 PLCH2 PRKCG PKN1 PLCB3 PKN3	1.46e-06	137	148	9	SM00239
Domain	-	ITCH CPNE5 SYT15B MCTP1 PLCH2 PRKCG PKN1 PLCB3 PKN3	2.78e-06	148	148	9	2.60.40.150
Domain	C2_dom	ITCH CPNE5 SYT15B MCTP1 PLCH2 PRKCG PKN1 PLCB3 PKN3	6.44e-06	164	148	9	IPR000008
Domain	RA	RALGDS RGL3 RADIL APBB1IP ARAP1	9.03e-06	36	148	5	PF00788
Domain	RA	RALGDS RGL3 RADIL APBB1IP ARAP1	1.04e-05	37	148	5	PS50200
Domain	RA_dom	RALGDS RGL3 RADIL APBB1IP ARAP1	1.54e-05	40	148	5	IPR000159
Domain	Hr1	RTKN PKN1 PKN3	1.67e-05	7	148	3	SM00742
Domain	C2	ITCH CPNE5 SYT15B MCTP1 PLCH2 PRKCG PKN1 PLCB3	1.76e-05	142	148	8	PS50004
Domain	HR1	RTKN PKN1 PKN3	2.65e-05	8	148	3	PF02185
Domain	HR1_rho-bd	RTKN CCDC120 PKN1 PKN3	4.21e-05	25	148	4	IPR011072
Domain	C2	ITCH CPNE5 SYT15B MCTP1 PLCH2 PRKCG PLCB3	8.37e-05	131	148	7	PF00168
Domain	RA	RALGDS RGL3 RADIL APBB1IP	1.01e-04	31	148	4	SM00314
Domain	PDZ	SHANK1 IL16 ARHGAP23 PDZD7 RADIL SCRIB MAST3	1.33e-04	141	148	7	PF00595
Domain	PDZ	SHANK1 IL16 ARHGAP23 PDZD7 RADIL SCRIB MAST3	1.79e-04	148	148	7	SM00228
Domain	muHD	FCHO2 FCHO1	1.86e-04	3	148	2	PF10291
Domain	Muniscin_C	FCHO2 FCHO1	1.86e-04	3	148	2	IPR018808
Domain	-	SHANK1 IL16 ARHGAP23 PDZD7 RADIL SCRIB MAST3	1.95e-04	150	148	7	2.30.42.10
Domain	PDZ	SHANK1 IL16 ARHGAP23 PDZD7 RADIL SCRIB MAST3	2.03e-04	151	148	7	PS50106
Domain	PDZ	SHANK1 IL16 ARHGAP23 PDZD7 RADIL SCRIB MAST3	2.11e-04	152	148	7	IPR001478
Domain	Pkinase	TRIO PSKH1 SPEG OBSCN BRSK2 TESK1 PRKCG PKN1 WNK2 PKN3 MAST3	2.32e-04	381	148	11	PF00069
Domain	SH3	SHANK1 AMPH TRIO NCKIPSD OBSCN CASKIN2 EPS8L3 ARHGAP33	3.31e-04	216	148	8	SM00326
Domain	SH3	SHANK1 AMPH TRIO NCKIPSD OBSCN CASKIN2 EPS8L3 ARHGAP33	3.31e-04	216	148	8	PS50002
Domain	Pkinase_C	PRKCG PKN1 PKN3 MAST3	3.35e-04	42	148	4	PF00433
Domain	SH3_domain	SHANK1 AMPH TRIO NCKIPSD OBSCN CASKIN2 EPS8L3 ARHGAP33	3.75e-04	220	148	8	IPR001452
Domain	Ser/Thr_kinase_AS	TRIO PSKH1 SPEG OBSCN BRSK2 PRKCG PKN1 WNK2 PKN3 MAST3	5.67e-04	357	148	10	IPR008271
Domain	S_TKc	TRIO PSKH1 SPEG OBSCN BRSK2 PRKCG PKN1 WNK2 PKN3 MAST3	5.92e-04	359	148	10	SM00220
Domain	FYrich_C	KMT2B KMT2D	6.14e-04	5	148	2	IPR003889
Domain	FYrich_N	KMT2B KMT2D	6.14e-04	5	148	2	IPR003888
Domain	NUT	NUTM2G NUTM2F	6.14e-04	5	148	2	IPR024310
Domain	NUT_N	NUTM2G NUTM2F	6.14e-04	5	148	2	IPR024309
Domain	FYRC	KMT2B KMT2D	6.14e-04	5	148	2	SM00542
Domain	FYRN	KMT2B KMT2D	6.14e-04	5	148	2	SM00541
Domain	NUT	NUTM2G NUTM2F	6.14e-04	5	148	2	PF12881
Domain	FYRN	KMT2B KMT2D	6.14e-04	5	148	2	PF05964
Domain	FYRC	KMT2B KMT2D	6.14e-04	5	148	2	PF05965
Domain	FYRC	KMT2B KMT2D	6.14e-04	5	148	2	PS51543
Domain	FYRN	KMT2B KMT2D	6.14e-04	5	148	2	PS51542
Domain	-	PKN1 PKN3	6.14e-04	5	148	2	1.10.287.160
Domain	PROTEIN_KINASE_ST	TRIO PSKH1 SPEG OBSCN BRSK2 PRKCG PKN1 WNK2 PKN3 MAST3	6.32e-04	362	148	10	PS00108
Domain	AGC-kinase_C	PRKCG PKN1 PKN3 MAST3	1.01e-03	56	148	4	IPR000961
Domain	AGC_KINASE_CTER	PRKCG PKN1 PKN3 MAST3	1.01e-03	56	148	4	PS51285
Domain	S_TK_X	PRKCG PKN1 PKN3 MAST3	1.01e-03	56	148	4	SM00133
Domain	PROTEIN_KINASE_ATP	TRIO PSKH1 SPEG OBSCN BRSK2 TESK1 PRKCG PKN1 WNK2 PKN3 MAST3	1.09e-03	459	148	11	PS00107
Domain	DUF3585	EHBP1L1 MICALL2	1.28e-03	7	148	2	IPR022735
Domain	DUF3585	EHBP1L1 MICALL2	1.28e-03	7	148	2	PF12130
Domain	Kinase-like_dom	TRIO PSKH1 SPEG OBSCN BRSK2 TESK1 PRKCG PKN1 WNK2 PKN3 MAST3 DNM2	1.29e-03	542	148	12	IPR011009
Domain	RhoGAP	ARHGAP23 SH3BP1 ARHGAP33 ARAP1	1.48e-03	62	148	4	SM00324
Domain	-	SHANK1 C19orf47 PPFIA3 CASKIN2 ARAP1	1.56e-03	106	148	5	1.10.150.50
Domain	RhoGAP	ARHGAP23 SH3BP1 ARHGAP33 ARAP1	1.57e-03	63	148	4	PF00620
Domain	DH_1	TRIO OBSCN ARHGEF17 FARP1	1.57e-03	63	148	4	PS00741
Domain	RhoGAP_dom	ARHGAP23 SH3BP1 ARHGAP33 ARAP1	1.66e-03	64	148	4	IPR000198
Domain	RHOGAP	ARHGAP23 SH3BP1 ARHGAP33 ARAP1	1.66e-03	64	148	4	PS50238
Domain	-	ARHGAP23 SH3BP1 ARHGAP33 ARAP1	1.66e-03	64	148	4	1.10.555.10
Domain	PTB	TNS4 EPS8L3	1.69e-03	8	148	2	IPR013625
Domain	PTB	TNS4 EPS8L3	1.69e-03	8	148	2	PF08416
Domain	Prot_kinase_dom	TRIO PSKH1 SPEG OBSCN BRSK2 TESK1 PRKCG PKN1 WNK2 PKN3 MAST3	1.81e-03	489	148	11	IPR000719
Domain	PROTEIN_KINASE_DOM	TRIO PSKH1 SPEG OBSCN BRSK2 TESK1 PRKCG PKN1 WNK2 PKN3 MAST3	1.93e-03	493	148	11	PS50011
Domain	RhoGEF	TRIO OBSCN ARHGEF17 FARP1	2.08e-03	68	148	4	SM00325
Domain	SAM_1	SHANK1 PPFIA3 CASKIN2 ARAP1	2.08e-03	68	148	4	PF00536
Domain	RhoGEF	TRIO OBSCN ARHGEF17 FARP1	2.31e-03	70	148	4	PF00621
Domain	DH_2	TRIO OBSCN ARHGEF17 FARP1	2.31e-03	70	148	4	PS50010
Domain	SAM/pointed	SHANK1 C19orf47 PPFIA3 CASKIN2 ARAP1	2.40e-03	117	148	5	IPR013761
Domain	-	TRIO OBSCN ARHGEF17 FARP1	2.44e-03	71	148	4	1.20.900.10
Domain	DH-domain	TRIO OBSCN ARHGEF17 FARP1	2.44e-03	71	148	4	IPR000219
Domain	Pkinase_C	PRKCG PKN1 PKN3	3.11e-03	37	148	3	IPR017892
Domain	ZF_CXXC	KMT2B MBD1	3.27e-03	11	148	2	PS51058
Domain	MBD	MBD1 MBD6	3.27e-03	11	148	2	SM00391
Domain	MBD	MBD1 MBD6	3.27e-03	11	148	2	PS50982
Domain	Znf_CXXC	KMT2B MBD1	3.27e-03	11	148	2	IPR002857
Domain	Methyl_CpG_DNA-bd	MBD1 MBD6	3.27e-03	11	148	2	IPR001739
Domain	MBD	MBD1 MBD6	3.27e-03	11	148	2	PF01429
Domain	DNA-bd_dom	MBD1 MBD6	3.27e-03	11	148	2	IPR016177
Domain	zf-CXXC	KMT2B MBD1	3.27e-03	11	148	2	PF02008
Domain	Ubiquitin-rel_dom	RALGDS RGL3 RADIL FARP1 BAG6 APBB1IP	3.50e-03	184	148	6	IPR029071
Domain	GDS_CDC24_CS	TRIO OBSCN FARP1	3.62e-03	39	148	3	IPR001331
Domain	PTB	APBB2 SHC2 TNS4	3.89e-03	40	148	3	SM00462
Domain	PTB/PI_dom	APBB2 SHC2 TNS4	4.17e-03	41	148	3	IPR006020
Domain	MHD	FCHO2 FCHO1	4.59e-03	13	148	2	PS51072
Domain	MHD	FCHO2 FCHO1	4.59e-03	13	148	2	IPR028565
Domain	SH3_2	SHANK1 AMPH CASKIN2 ARHGAP33	4.86e-03	86	148	4	PF07653
Domain	SH3_2	SHANK1 AMPH CASKIN2 ARHGAP33	4.86e-03	86	148	4	IPR011511
Domain	Rho_GTPase_activation_prot	ARHGAP23 SH3BP1 ARHGAP33 ARAP1	5.28e-03	88	148	4	IPR008936
Domain	SAM	SHANK1 PPFIA3 CASKIN2 ARAP1	5.28e-03	88	148	4	SM00454
Domain	Ras_G-nucl-exch_fac_CS	RALGDS RGL3	5.33e-03	14	148	2	IPR019804
Domain	BAR	AMPH SH3BP1	6.12e-03	15	148	2	SM00721
Domain	EF-hand_like	PLCH2 PLCB3	6.12e-03	15	148	2	PF09279
Domain	PI-PLC-Y	PLCH2 PLCB3	6.12e-03	15	148	2	PF00387
Domain	PLCYc	PLCH2 PLCB3	6.12e-03	15	148	2	SM00149
Domain	PLipase_C_Pinositol-sp_Y	PLCH2 PLCB3	6.12e-03	15	148	2	IPR001711
Domain	PIPLC_Y_DOMAIN	PLCH2 PLCB3	6.12e-03	15	148	2	PS50008
Domain	BAR	AMPH SH3BP1	6.12e-03	15	148	2	PF03114
Domain	PI-PLC_fam	PLCH2 PLCB3	6.12e-03	15	148	2	IPR001192
Domain	PLC_EF-hand-like	PLCH2 PLCB3	6.12e-03	15	148	2	IPR015359
Domain	SAM_DOMAIN	SHANK1 PPFIA3 CASKIN2 ARAP1	6.90e-03	95	148	4	PS50105
Pathway	REACTOME_RHOA_GTPASE_CYCLE	TRIO ARHGAP23 OBSCN RTKN ARHGEF17 FARP1 PKN1 PKN3 ARAP1	1.01e-06	142	104	9	MM15576
Pathway	REACTOME_RHOA_GTPASE_CYCLE	TRIO ARHGAP23 OBSCN RTKN ARHGEF17 FARP1 PKN1 PKN3 ARAP1	1.51e-06	149	104	9	M41805
Pathway	PID_THROMBIN_PAR1_PATHWAY	PRKCG PKN1 PLCB3 NOS3 DNM2	1.53e-05	43	104	5	M238
Pathway	PID_RHOA_REG_PATHWAY	TRIO OBSCN ARHGEF17 FARP1 ARAP1	2.14e-05	46	104	5	M68
Pathway	REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3	CENPA TRIO ARHGAP23 NCKIPSD SH3BP1 OBSCN RTKN ARHGEF17 FARP1 PKN1 SCRIB NUP160 PKN3 ARHGAP33 ARAP1	7.96e-05	649	104	15	MM15690
Pathway	REACTOME_RHO_GTPASE_CYCLE	TRIO ARHGAP23 SH3BP1 OBSCN RTKN ARHGEF17 FARP1 PKN1 SCRIB PKN3 ARHGAP33 ARAP1	9.26e-05	439	104	12	MM15595
Pathway	REACTOME_RHO_GTPASE_CYCLE	TRIO ARHGAP23 SH3BP1 OBSCN RTKN ARHGEF17 FARP1 PKN1 SCRIB PKN3 ARHGAP33 ARAP1	1.17e-04	450	104	12	M27078
Pathway	REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES	SHANK1 NLGN4Y LRFN3 GRIN2D PPFIA3	1.33e-04	67	104	5	MM15327
Pathway	REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3	CENPA TRIO ARHGAP23 NCKIPSD SH3BP1 OBSCN RTKN ARHGEF17 FARP1 PKN1 SCRIB NUP160 PKN3 ARHGAP33 ARAP1	2.49e-04	720	104	15	M41838
Pathway	REACTOME_RAC1_GTPASE_CYCLE	TRIO ARHGAP23 SH3BP1 FARP1 PKN1 ARHGAP33 ARAP1	3.11e-04	175	104	7	MM15599
Pathway	KEGG_CALCIUM_SIGNALING_PATHWAY	CACNA1C GRIN2D EDNRB ITPKB PRKCG PLCB3 NOS3	3.45e-04	178	104	7	M2890
Pathway	REACTOME_RAC1_GTPASE_CYCLE	TRIO ARHGAP23 SH3BP1 FARP1 PKN1 ARHGAP33 ARAP1	4.21e-04	184	104	7	M41809
Pathway	REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES	SHANK1 NLGN4Y LRFN3 GRIN2D PPFIA3	4.54e-04	87	104	5	M27617
Pathway	REACTOME_NOSTRIN_MEDIATED_ENOS_TRAFFICKING	NOS3 DNM2	5.31e-04	5	104	2	M27112
Pathway	REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK	BCL2L11 TRIO OBSCN ARHGEF17	5.77e-04	52	104	4	MM14743
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TRNP1 KMT2B BCL2L11 PCNX3 TRIO UBE4B BICRA SPEG C19orf47 OBSCN ZDHHC5 ANKLE1 GRIN2D MBD6 FAAP100 TESK1 KIFC2 RADIL EHBP1L1 HEG1 KMT2D EPOP ZNRF3 PKN1 SLC45A1 CABIN1 WNK2 PKN3 ARHGAP33 ARAP1	5.89e-15	1105	162	30	35748872
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	SHANK1 VGF ITCH TRIO PRR36 SH3BP1 TRIOBP GRIN2D PPFIA3 BCOR PABPC1 SLC12A5 FARP1 YLPM1 PRKCG PKN1 MTCL1 SCRIB CABIN1 WNK2 DNM2 AGAP2	8.84e-10	963	162	22	28671696
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	ITCH TRIO MBD1 NCKIPSD C19orf47 BRSK2 CBARP RTKN ARHGEF17 TESK1 PABPC1 PABIR2 ITPKB RADIL CASKIN2 PRKCG MTCL1 SCRIB SRRM2 KIF1C	4.15e-09	861	162	20	36931259
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	USP36 DDX31 TRIO DUSP8 ZDHHC5 TRIOBP CBARP XRCC1 PPFIA3 FCHO2 BCOR CCDC61 PABIR2 KMT2D CASKIN2 FARP1 TLE3 YLPM1 MARVELD2 SCRIB SRRM2	2.18e-08	1049	162	21	27880917
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	USP36 IL16 ITCH ARHGAP23 P3H3 BICRA MBD1 PPFIA3 BCOR CHAMP1 SOWAHA MCTP1 ZNRF3 ATXN7 HRES1 SCRIB SRRM2 INO80B ARHGAP33 TBX2	2.85e-07	1116	162	20	31753913
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	KMT2B CENPA SCARF2 BICRA NCKIPSD GRIN2D XRCC1 PPFIA3 KIFC2 WNK2 DNM2	4.61e-07	329	162	11	17474147
Pubmed	WW domains provide a platform for the assembly of multiprotein networks.	ITCH CHAMP1 PABPC1 TLE3 YLPM1 SRRM2 APBB1IP DNM2	6.83e-07	154	162	8	16055720
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	SHANK1 AMPH IL16 TRIO ARHGAP23 PRR36 NCKIPSD BRSK2 BCAN SRCIN1 PPFIA3 ARHGEF17 PABPC1 ITPKB SLC12A5 FARP1 PRKCG SCRIB CROCC WNK2 DNM2 AGAP2	9.19e-07	1431	162	22	37142655
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	SPEG SRCIN1 GRIN2D PPFIA3 PABPC1 SRRM2 ARHGAP33 MAST3 AGAP2	1.51e-06	231	162	9	16452087
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	UBE4B SPEG ARHGEF17 SLC12A5 ZFR2 TLE3 DENND4B MTCL1 SCRIB CROCC SRRM2	3.63e-06	407	162	11	12693553
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	CACNA1C BRSK2 ZDHHC5 CBARP BCAN SRCIN1 RADIL PRKCG SRRM2 AGAP2	5.81e-06	347	162	10	17114649
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	SHANK1 AMPH TRIO UBE4B NLGN4Y SRCIN1 GRIN2D PRKCG AGAP2	7.42e-06	281	162	9	28706196
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	KMT2B UBE4B BCOR CHAMP1 KMT2D ATXN7 TLE3 YLPM1 PKN1 PLCB3 SCRIB SRRM2 BAG6 DNM2	1.73e-05	774	162	14	15302935
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	CACNA1C ITCH TRIO UBE4B RTEL1 NLGN4Y BICRA OBSCN APBB2 TRIOBP SRCIN1 ITPKB SHC2 ATXN7 FARP1 TLE3 PKN1 CROCC WNK2 ARAP1	2.16e-05	1489	162	20	28611215
Pubmed	BH3-only protein Bim more critical than Puma in tyrosine kinase inhibitor-induced apoptosis of human leukemic cells and transduced hematopoietic progenitors carrying oncogenic FLT3.	BCL2L11 BBC3	2.16e-05	2	162	2	19064725
Pubmed	PUMA and BIM are required for oncogene inactivation-induced apoptosis.	BCL2L11 BBC3	2.16e-05	2	162	2	23532334
Pubmed	Inositol 1,3,4,5-tetrakisphosphate controls proapoptotic Bim gene expression and survival in B cells.	BCL2L11 ITPKB	2.16e-05	2	162	2	17709751
Pubmed	Kabuki syndrome stem cell models reveal locus specificity of histone methyltransferase 2D (KMT2D/MLL4).	KMT2B KMT2D	2.16e-05	2	162	2	35640156
Pubmed	Puma cooperates with Bim, the rate-limiting BH3-only protein in cell death during lymphocyte development, in apoptosis induction.	BCL2L11 BBC3	2.16e-05	2	162	2	17178918
Pubmed	Perturbation of dynamin II with an amphiphysin SH3 domain increases GLUT4 glucose transporters at the plasma membrane in 3T3-L1 adipocytes. Dynamin II participates in GLUT4 endocytosis.	AMPH DNM2	2.16e-05	2	162	2	9525921
Pubmed	E2F1 regulates the base excision repair gene XRCC1 and promotes DNA repair.	E2F1 XRCC1	2.16e-05	2	162	2	18348985
Pubmed	A clathrin coat assembly role for the muniscin protein central linker revealed by TALEN-mediated gene editing.	FCHO2 FCHO1	2.16e-05	2	162	2	25303365
Pubmed	Tricellulin is a target of the ubiquitin ligase Itch.	ITCH MARVELD2	2.16e-05	2	162	2	28436082
Pubmed	The proapoptotic BH3-only proteins Bim and Puma are downstream of endoplasmic reticulum and mitochondrial oxidative stress in pancreatic islets in response to glucotoxicity.	BCL2L11 BBC3	2.16e-05	2	162	2	24625983
Pubmed	BH3-only proteins BIM and PUMA in the regulation of survival and neuronal differentiation of newly generated cells in the adult mouse hippocampus.	BCL2L11 BBC3	2.16e-05	2	162	2	21364616
Pubmed	Orthologous relationship of obscurin and Unc-89: phylogeny of a novel family of tandem myosin light chain kinases.	SPEG OBSCN	2.16e-05	2	162	2	15185077
Pubmed	Targeted delivery of siRNA to cell death proteins in sepsis.	BCL2L11 BBC3	2.16e-05	2	162	2	19033888
Pubmed	Dynamin2- and endothelial nitric oxide synthase-regulated invasion of bladder epithelial cells by uropathogenic Escherichia coli.	NOS3 DNM2	2.16e-05	2	162	2	21220511
Pubmed	Palmitoleate attenuates palmitate-induced Bim and PUMA up-regulation and hepatocyte lipoapoptosis.	BCL2L11 BBC3	2.16e-05	2	162	2	20206402
Pubmed	Amphiphysin1 inhibits vitronectin-mediated cell adhesion, spreading, and migration in vitro.	AMPH VTN	2.16e-05	2	162	2	12565847
Pubmed	UBE4B interacts with the ITCH E3 ubiquitin ligase to induce Ku70 and c-FLIPL polyubiquitination and enhanced neuroblastoma apoptosis.	ITCH UBE4B	2.16e-05	2	162	2	37957138
Pubmed	The joint effect of the endothelin receptor B gene (EDNRB) polymorphism rs10507875 and nitric oxide synthase 3 gene (NOS3) polymorphism rs869109213 in Slovenian patients with type 2 diabetes mellitus and diabetic retinopathy.	EDNRB NOS3	2.16e-05	2	162	2	28817788
Pubmed	Comparison of methylation episignatures in KMT2B- and KMT2D-related human disorders.	KMT2B KMT2D	2.16e-05	2	162	2	35506254
Pubmed	Bim, a proapoptotic protein, up-regulated via transcription factor E2F1-dependent mechanism, functions as a prosurvival molecule in cancer.	BCL2L11 E2F1	2.16e-05	2	162	2	23152504
Pubmed	Angiotensin AT1 receptor-associated protein Arap1 in the kidney vasculature is suppressed by angiotensin II.	NOS3 ARAP1	2.16e-05	2	162	2	22357923
Pubmed	Bcl-2 homology domain 3-only proteins Puma and Bim mediate the vulnerability of CA1 hippocampal neurons to proteasome inhibition in vivo.	BCL2L11 BBC3	2.16e-05	2	162	2	21198986
Pubmed	Thiazolides promote apoptosis in colorectal tumor cells via MAP kinase-induced Bim and Puma activation.	BCL2L11 BBC3	2.16e-05	2	162	2	26043078
Pubmed	DR5 and caspase-8 are dispensable in ER stress-induced apoptosis.	BCL2L11 BBC3	2.16e-05	2	162	2	28409774
Pubmed	[E2F1 upregulates endogenous XRCC1 expression].	E2F1 XRCC1	2.16e-05	2	162	2	19031698
Pubmed	Implication of amphiphysin 1 and dynamin 2 in tubulobulbar complex formation and spermatid release.	AMPH DNM2	2.16e-05	2	162	2	17785912
Pubmed	An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase.	RBM33 ZDHHC5 BCOR YLPM1 CCDC120 CROCC NUP160	2.30e-05	180	162	7	35198878
Pubmed	SUMOylation of DDX39A Alters Binding and Export of Antiviral Transcripts to Control Innate Immunity.	CENPA ARHGAP23 PLEKHA4 PDZD7 FCHO1 ITPKB SSC5D EPOP WFIKKN1 FAM157A PRKCG PPP1R35 MARVELD2 NOS3 TBX2	2.69e-05	915	162	15	32393512
Pubmed	EHBP1L1 coordinates Rab8 and Bin1 to regulate apical-directed transport in polarized epithelial cells.	AMPH EHBP1L1 MICALL2	2.74e-05	13	162	3	26833786
Pubmed	Quantitative phosphoproteome analysis using a dendrimer conjugation chemistry and tandem mass spectrometry.	TRIO MBD1 DOK2 CASKIN2 C1QTNF4	3.74e-05	80	162	5	16094384
Pubmed	Neuronal interleukin-16 (NIL-16): a dual function PDZ domain protein.	CACNA1C IL16 GRIN2D	4.33e-05	15	162	3	10479680
Pubmed	Differential physiological roles for BIN1 isoforms in skeletal muscle development, function and regeneration.	CACNA1C AMPH DNM2	5.31e-05	16	162	3	32994313
Pubmed	The DNA sequence and biology of human chromosome 19.	KMT2B CBARP XRCC1 CCDC61 SHC2 ARHGAP33 MAST3 DNM2	5.98e-05	284	162	8	15057824
Pubmed	EHBP1L1, an apicobasal polarity regulator, is critical for nuclear polarization during enucleation of erythroblasts.	AMPH EHBP1L1 DNM2	6.43e-05	17	162	3	37042948
Pubmed	Dynamin-2 reduction rescues the skeletal myopathy of a SPEG-deficient mouse model.	SPEG DNM2	6.45e-05	3	162	2	35763354
Pubmed	Dynamin isoform-specific interaction with the shank/ProSAP scaffolding proteins of the postsynaptic density and actin cytoskeleton.	SHANK1 DNM2	6.45e-05	3	162	2	11583995
Pubmed	Deficiency in Bim, Bid and Bbc3 (Puma) do not prevent axonal injury induced death.	BCL2L11 BBC3	6.45e-05	3	162	2	22996683
Pubmed	BH3-only proteins are part of a regulatory network that control the sustained signalling of the unfolded protein response sensor IRE1α.	BCL2L11 BBC3	6.45e-05	3	162	2	22510886
Pubmed	Broad degradation of proapoptotic proteins with the conserved Bcl-2 homology domain 3 during infection with Chlamydia trachomatis.	BCL2L11 BBC3	6.45e-05	3	162	2	15731037
Pubmed	Degradation of the proapoptotic proteins Bik, Puma, and Bim with Bcl-2 domain 3 homology in Chlamydia trachomatis-infected cells.	BCL2L11 BBC3	6.45e-05	3	162	2	15731089
Pubmed	Protein kinase N2 mediates flow-induced endothelial NOS activation and vascular tone regulation.	PKN1 NOS3	6.45e-05	3	162	2	34499618
Pubmed	The BH3-only proteins BIM and PUMA are not critical for the reticulocyte apoptosis caused by loss of the pro-survival protein BCL-XL.	BCL2L11 BBC3	6.45e-05	3	162	2	28682312
Pubmed	The phosphatidyl inositol 3 kinase pathway does not suppress activation of the ARF and BIM genes by deregulated E2F1 activity.	BCL2L11 E2F1	6.45e-05	3	162	2	27888102
Pubmed	Identification of a putative target for Rho as the serine-threonine kinase protein kinase N.	PKN1 PKN3	6.45e-05	3	162	2	8571127
Pubmed	Molecular analysis of neutrophil spontaneous apoptosis reveals a strong role for the pro-apoptotic BH3-only protein Noxa.	BCL2L11 BBC3	6.45e-05	3	162	2	21660046
Pubmed	PKN regulates phospholipase D1 through direct interaction.	PKN1 PKN3	6.45e-05	3	162	2	11259428
Pubmed	Polycomb protein EZH2 regulates E2F1-dependent apoptosis through epigenetically modulating Bim expression.	BCL2L11 E2F1	6.45e-05	3	162	2	19893569
Pubmed	Melatonin induces apoptotic cell death through Bim stabilization by Sp1-mediated OTUD1 upregulation.	BCL2L11 OTUD1	6.45e-05	3	162	2	34826170
Pubmed	Association Between eNOS, MMP-9, BAG-6 Gene Polymorphisms and Risk of Hypertensive Disorders of Pregnancy in the Northern Chinese Population.	BAG6 NOS3	6.45e-05	3	162	2	33539267
Pubmed	AMP kinase-mediated activation of the BH3-only protein Bim couples energy depletion to stress-induced apoptosis.	BCL2L11 BBC3	6.45e-05	3	162	2	20351066
Pubmed	Histone methyltransferase MLL4 controls myofiber identity and muscle performance through MEF2 interaction.	KMT2B KMT2D	6.45e-05	3	162	2	32544095
Pubmed	Apoptosis signal-regulating kinase 1 is a direct target of E2F1 and contributes to histone deacetylase inhibitor-induced apoptosis through positive feedback regulation of E2F1 apoptotic activity.	BCL2L11 E2F1	6.45e-05	3	162	2	16476732
Pubmed	The histone methyltransferase KMT2B is required for RNA polymerase II association and protection from DNA methylation at the MagohB CpG island promoter.	KMT2B KMT2D	6.45e-05	3	162	2	23358417
Pubmed	Liquid-like protein interactions catalyse assembly of endocytic vesicles.	FCHO2 FCHO1	6.45e-05	3	162	2	33820972
Pubmed	Relation of candidate genes that encode for endothelial function to migraine and stroke: the Stroke Prevention in Young Women study.	EDNRB NOS3	6.45e-05	3	162	2	19661472
Pubmed	Cerebral vasoconstriction reactions and plasma levels of ETBR, ET-1, and eNOS in patients with chronic high altitude disease.	EDNRB NOS3	6.45e-05	3	162	2	27485004
Pubmed	Role of BH3-only molecules Bim and Puma in β-cell death in Pdx1 deficiency.	BCL2L11 BBC3	6.45e-05	3	162	2	24658302
Pubmed	Disease-causing point-mutations in metal-binding domains of Wilson disease protein decrease stability and increase structural dynamics.	MBD1 MBD6	6.45e-05	3	162	2	27744583
Pubmed	Regulatory domain selectivity in the cell-type specific PKN-dependence of cell migration.	PKN1 PKN3	6.45e-05	3	162	2	21754995
Pubmed	Hypercontractile female hearts exhibit increased S-nitrosylation of the L-type Ca2+ channel alpha1 subunit and reduced ischemia/reperfusion injury.	CACNA1C NOS3	6.45e-05	3	162	2	16397145
Pubmed	Enzyme kinetics and distinct modulation of the protein kinase N family of kinases by lipid activators and small molecule inhibitors.	PKN1 PKN3	6.45e-05	3	162	2	27919031
Pubmed	BBC3 (PUMA) regulates developmental apoptosis but not axonal injury induced death in the retina.	BCL2L11 BBC3	6.45e-05	3	162	2	21762490
Pubmed	Protein interactome reveals converging molecular pathways among autism disorders.	SHANK1 CACNA1C MBD1 CAPN3 NCKIPSD PLEKHA4 TRIOBP GPR162 ZNRF3 DNM2 KIF1C	6.86e-05	560	162	11	21653829
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ARHGAP23 RTEL1 COL27A1 BRSK2 ZDHHC5 FCHO1 RADIL NUP160 MAST3 KIF1C	1.14e-04	493	162	10	15368895
Pubmed	Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.	RBM33 BICRA BCOR PABPC1 TLE3 YLPM1 SCRIB SRRM2 BAG6	1.14e-04	399	162	9	35987950
Pubmed	Crucial roles for interactions between MLL3/4 and INI1 in nuclear receptor transactivation.	KMT2B KMT2D	1.29e-04	4	162	2	19221051
Pubmed	BH3-only proteins Puma and Bim are rate-limiting for gamma-radiation- and glucocorticoid-induced apoptosis of lymphoid cells in vivo.	BCL2L11 BBC3	1.29e-04	4	162	2	16118324
Pubmed	Multiple triggers of cell death in sepsis: death receptor and mitochondrial-mediated apoptosis.	BCL2L11 BBC3	1.29e-04	4	162	2	17307841
Pubmed	BH3-only proteins Noxa, Bmf, and Bim are necessary for arsenic trioxide-induced cell death in myeloma.	BCL2L11 BBC3	1.29e-04	4	162	2	18354037
Pubmed	Loss of Prkar1a leads to Bcl-2 family protein induction and cachexia in mice.	BCL2L11 BBC3	1.29e-04	4	162	2	25012505
Pubmed	The intestinal quorum sensing 3-oxo-C12:2 Acyl homoserine lactone limits cytokine-induced tight junction disruption.	ITCH MARVELD2	1.29e-04	4	162	2	33100129
Pubmed	Inducing mutations in the mouse genome with the chemical mutagen ethylnitrosourea.	KMT2D OTOP1	1.29e-04	4	162	2	16972005
Pubmed	Novel pro-survival functions of the Kruppel-like transcription factor Egr2 in promotion of macrophage colony-stimulating factor-mediated osteoclast survival downstream of the MEK/ERK pathway.	BCL2L11 CSF1	1.29e-04	4	162	2	18198176
Pubmed	BCL-XL exerts a protective role against anemia caused by radiation-induced kidney damage.	BCL2L11 BBC3	1.29e-04	4	162	2	33236795
Pubmed	Cutting edge: regulatory T cells do not mediate suppression via programmed cell death pathways.	BCL2L11 BBC3	1.29e-04	4	162	2	21949016
Pubmed	The calcineurin-binding protein cain is a negative regulator of synaptic vesicle endocytosis.	AMPH CABIN1	1.29e-04	4	162	2	10931822
Pubmed	Loss of the BH3-only protein Bmf impairs B cell homeostasis and accelerates gamma irradiation-induced thymic lymphoma development.	BCL2L11 BBC3	1.29e-04	4	162	2	18299399
Pubmed	Endothelial nitric oxide synthase interactions with G-protein-coupled receptors.	EDNRB NOS3	1.29e-04	4	162	2	10510297
Pubmed	Role of proapoptotic BH3-only proteins in Listeria monocytogenes infection.	BCL2L11 BBC3	1.29e-04	4	162	2	27064265
Pubmed	Mature neurons dynamically restrict apoptosis via redundant premitochondrial brakes.	BCL2L11 BBC3	1.29e-04	4	162	2	27797453
Pubmed	Kif5B and Kifc1 interact and are required for motility and fission of early endocytic vesicles in mouse liver.	KIFC2 KIF1C	1.29e-04	4	162	2	17360972
Pubmed	Exocytosis regulates trafficking of GABA and glycine heterotransporters in spinal cord glutamatergic synapses: a mechanism for the excessive heterotransporter-induced release of glutamate in experimental amyotrophic lateral sclerosis.	AMPH SLC6A5	1.29e-04	4	162	2	25497732
Pubmed	MAP4K3 modulates cell death via the post-transcriptional regulation of BH3-only proteins.	BCL2L11 BBC3	1.29e-04	4	162	2	19587239
Pubmed	Maximal killing of lymphoma cells by DNA damage-inducing therapy requires not only the p53 targets Puma and Noxa, but also Bim.	BCL2L11 BBC3	1.29e-04	4	162	2	20829369
Pubmed	Distinct and separable activities of the endocytic clathrin-coat components Fcho1/2 and AP-2 in developmental patterning.	FCHO2 FCHO1	1.29e-04	4	162	2	22484487
Pubmed	Mcl-1 as a buffer for proapoptotic Bcl-2 family members during TRAIL-induced apoptosis: a mechanistic basis for sorafenib (Bay 43-9006)-induced TRAIL sensitization.	BCL2L11 BBC3	1.29e-04	4	162	2	17698840
Interaction	TOP3B interactions	TRNP1 KMT2B BCL2L11 PCNX3 TRIO UBE4B RTEL1 RBM33 BICRA SPEG C19orf47 OBSCN PLEKHA4 ZDHHC5 ANKLE1 GRIN2D MBD6 FAAP100 TESK1 PABPC1 KIFC2 RADIL EHBP1L1 HEG1 KMT2D EPOP ZNRF3 PKN1 SLC45A1 CABIN1 WNK2 PKN3 ARHGAP33 ARAP1	8.76e-09	1470	158	34	int:TOP3B
Interaction	NCK1 interactions	FNDC3B RTEL1 SCARF2 NCKIPSD APBB2 DOK2 CPNE5 FCHO1 CASKIN2 NUTM2F ARAP1 DNM2	5.24e-07	244	158	12	int:NCK1
Cytoband	Ensembl 112 genes in cytogenetic band chr19q13	SHANK1 KMT2B BICRA LRFN3 C19orf47 PLEKHA4 GRIN2D XRCC1 PPFIA3 CCDC61 SSC5D PRR19 PRKCG BBC3 ARHGAP33	2.35e-05	1192	162	15	chr19q13
Cytoband	Ensembl 112 genes in cytogenetic band chr19p13	PRR36 RGL3 TGFBR3L CBARP ANKLE1 FCHO1 SHC2 ZFR2 PKN1 MAST3 DNM2	1.35e-04	797	162	11	chr19p13
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ARHGAP23 PLEKHA4 TRIOBP RTKN FARP1 APBB1IP ARAP1 DNM2 AGAP2	2.11e-06	206	100	9	682
GeneFamily	C2 domain containing protein kinases	PRKCG PKN1 PKN3	1.92e-05	10	100	3	835
GeneFamily	PDZ domain containing	SHANK1 IL16 ARHGAP23 PDZD7 RADIL SCRIB MAST3	2.15e-05	152	100	7	1220
GeneFamily	Ankyrin repeat domain containing	SHANK1 ANKLE1 BCOR SOWAHA CASKIN2 ARAP1 AGAP2	3.93e-04	242	100	7	403
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	TRIO OBSCN ARHGEF17 FARP1	4.88e-04	66	100	4	722
GeneFamily	Sterile alpha motif domain containing	SHANK1 PPFIA3 CASKIN2 ARAP1	1.44e-03	88	100	4	760
GeneFamily	BCL2 homology region 3 (BH3) only	BCL2L11 BBC3	1.61e-03	11	100	2	1277
GeneFamily	Zinc fingers CXXC-type\|Methyl-CpG binding domain containing	MBD1 MBD6	1.61e-03	11	100	2	1025
GeneFamily	Zinc fingers CXXC-type	KMT2B MBD1	1.93e-03	12	100	2	136
GeneFamily	N-BAR domain containing	AMPH SH3BP1	1.93e-03	12	100	2	1289
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	TRIO SPEG LRFN3 OBSCN WFIKKN1	2.01e-03	161	100	5	593
GeneFamily	Rho GTPase activating proteins\|BCH domain containing	ARHGAP23 SH3BP1 ARHGAP33	2.67e-03	50	100	3	721
GeneFamily	Rho GTPase activating proteins\|F-BAR domain containing	FCHO2 FCHO1	7.10e-03	23	100	2	1288
Coexpression	E2F1_UP.V1_DN	TRAF3IP2 RALGDS APBB2 RTKN FCHO1 CSF1 ZFR2 APBB1IP	1.96e-05	187	159	8	M2630
Coexpression	PGF_UP.V1_DN	VGF CACNA1C TRIO SH3BP1 OBSCN KMT2D ZFR2 UTF1	2.19e-05	190	159	8	M2673
Coexpression	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP	CCDC117 PRR36 DUSP8 BCOR TESK1 KIFC2 SLC2A10 KMT2D TLE3 DENND4B SRRM2	2.47e-05	385	159	11	M2840
Coexpression	PTEN_DN.V2_DN	DDX31 FRAT1 BCOR KMT2D NOS3 APBB1IP ARHGAP33	2.77e-05	143	159	7	M2758
Coexpression	GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_DN	FNDC3B CENPA LRFN3 CAPN3 ITPKB PLCH2 CABIN1 NOS3	2.84e-05	197	159	8	M3438
Coexpression	GSE10240_IL22_VS_IL22_AND_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN	GPR137 TRAF3IP2 BCL2L11 PRR36 FCHO1 ITPKB CASKIN2 SRRM2	3.17e-05	200	159	8	M309
Coexpression	GSE21670_TGFB_VS_IL6_TREATED_CD4_TCELL_UP	CACNA1C VTN RSPH4A ARHGAP23 BRSK2 GRIN2D FARP1 ZNF513	3.17e-05	200	159	8	M7437
Coexpression	GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS	SCARF2 COL27A1 OBSCN PLEKHA4 ARHGEF17 EDNRB HEG1 CSF1 MCTP1 SHC2 CLEC14A TBX2	6.33e-05	505	159	12	M39167
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VGF CBARP SRCIN1 PPFIA3 CPNE5 SLC12A5 PRKCG C1QTNF4 SRRM3	3.71e-08	193	161	9	be28070c049e7cb68bcd54f582226eb2f5e4bc1c
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VGF CBARP SRCIN1 PPFIA3 CPNE5 SLC12A5 PRKCG C1QTNF4 SRRM3	3.71e-08	193	161	9	0c652ebe22ce5d2927599dd97ef1920547858395
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VGF CBARP SRCIN1 PPFIA3 CPNE5 SLC12A5 PRKCG C1QTNF4 SRRM3	3.71e-08	193	161	9	8689a70a33a7c3823dc647d41ac0160e7c3ae396
ToppCell	LPS-IL1RA-Hematopoietic_Meg-Ery-Mes-Epi-like\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PSKH1 COL27A1 BCOR KIFC2 WFIKKN1 MARVELD2 ARHGAP33 ZNF513	1.10e-07	157	161	8	bd45590da540a557dc8096980a45220fccb99505
ToppCell	LPS-IL1RA-Hematopoietic_Meg-Ery-Mes-Epi-like-Erythroid\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PSKH1 COL27A1 BCOR KIFC2 WFIKKN1 MARVELD2 ARHGAP33 ZNF513	1.10e-07	157	161	8	00c9a58b033b8b95b0d838f233dd077b62d8b02a
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SUSD4 EDNRB ITPKB HEG1 MCTP1 CASKIN2 CLEC14A PKN3	5.11e-07	192	161	8	c618ede75dce3988c87a5b8f98d8e94e1dd66efd
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	P3H3 PSKH1 SPEG NCKIPSD ZDHHC5 PRR25 NPAP1	6.86e-07	137	161	7	0c82f815c014d01213d23b466043d6e57186dceb
ToppCell	343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	RGL3 WNT2B EDNRB C1QTNF4 CABIN1 BBC3 TBX2	7.57e-07	139	161	7	2fdc8f36510aff24abbc79ef2a842db75a85f946
ToppCell	343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	RGL3 WNT2B EDNRB C1QTNF4 CABIN1 BBC3 TBX2	7.57e-07	139	161	7	5970a654c64e3b54f9d18c102f5b125eec892fc5
ToppCell	5'-Adult-LymphNode-Endothelial-blood_vessel_EC-arterial_capillary\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	WWC2-AS2 EDNRB ITPKB MCTP1 CASKIN2 CLEC14A PKN3	3.94e-06	178	161	7	360d7a987f91d6d721487a921824057ec31a7332
ToppCell	droplet-Liver-LIVER_NPC-30m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DDX31 SCARF2 SLC12A5 MCTP1 CASKIN2 CLEC14A PKN3	4.08e-06	179	161	7	025d414ec88d5680d99c8173e70ee3bb0b694f74
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CENPA MBD1 CCDC61 PABIR2 EDNRB RITA1 PKN3	4.08e-06	179	161	7	327cc39161741ddbc4e8d45b9b3d30b3ce508929
ToppCell	facs-Heart-RA-24m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	USP36 EDNRB CASKIN2 CLEC14A TMEM108 NOS3 PKN3	4.24e-06	180	161	7	174c643e046646e3b305dd7e5b120d2c9a46690f
ToppCell	LA-07._Pericyte\|World / Chamber and Cluster_Paper	CACNA1C RGL3 COL27A1 APBB2 ARHGEF17 AGAP2 TBX2	4.72e-06	183	161	7	e3835db4795362b0442d5893baf2a78efcc20428
ToppCell	COVID-19-Heart-Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	CACNA1C SUSD4 RGL3 COL27A1 ARHGEF17 AGAP2 TBX2	4.90e-06	184	161	7	21790cdfa3b4036ad413fd44b94e31563116f25f
ToppCell	LA-07._Pericyte\|LA / Chamber and Cluster_Paper	CACNA1C RGL3 COL27A1 APBB2 ARHGEF17 AGAP2 TBX2	5.07e-06	185	161	7	ba5baa4d7f097108622674de5b7f4fd279843d24
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RALGDS CBARP TESK1 PABPC1 HEG1 PLCH2 KIF1C	5.26e-06	186	161	7	bd1185592aedebccd1007dbf2dd2f549fcdf9f42
ToppCell	facs-Heart-LA-24m-Endothelial-endothelial_cell_of_endocardium\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OTUD1 PABIR2 EDNRB HEG1 CLEC14A TMEM108 NOS3	5.44e-06	187	161	7	d9943e65eedab73d141eae524e2411653a751705
ToppCell	RV-07._Pericyte\|World / Chamber and Cluster_Paper	CACNA1C RGL3 COL27A1 APBB2 ARHGEF17 AGAP2 TBX2	5.44e-06	187	161	7	dc274d6bbda619a2c914d84e2b4069cfef1739d1
ToppCell	facs-Heart-LA-24m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OTUD1 PABIR2 EDNRB HEG1 CLEC14A TMEM108 NOS3	5.44e-06	187	161	7	7b13c3b67d66f3afb410141d5471c9e78a4d8623
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VGF PPFIA3 GPR162 KIFC2 PLCH2 PRKCG AGAP2	5.44e-06	187	161	7	e04a84989d624378141042768383b9c846901f2d
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VGF PPFIA3 GPR162 KIFC2 PLCH2 PRKCG AGAP2	5.44e-06	187	161	7	24cc03c748e15f7ef0e6509ca5a6ca583fb9c573
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VGF PPFIA3 GPR162 KIFC2 PLCH2 PRKCG AGAP2	5.44e-06	187	161	7	2f153b203fe79f206319603cf94d3a03ab49a05d
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EDNRB ITPKB HEG1 MCTP1 CASKIN2 CLEC14A PKN3	5.64e-06	188	161	7	73f6ec915934154f435a376cb274b058ff7c5f35
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SUSD4 EDNRB ITPKB HEG1 MCTP1 CASKIN2 CLEC14A	5.64e-06	188	161	7	789d1be574e693d7bdd488f3c72c6df788e47b47
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	AMPH COL27A1 OBSCN EDNRB FARP1 NOTO TBX2	5.64e-06	188	161	7	997dcfc4f08738ab398d8abc15e4fd2fc6619862
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP23 EDNRB SLC2A10 CASKIN2 CLEC14A NOS3 PKN3	5.84e-06	189	161	7	e60a3d6aa84788c29f23439f1c747431ea581bc3
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SUSD4 APBB2 EDNRB HEG1 MCTP1 CASKIN2 CLEC14A	6.04e-06	190	161	7	474cbbab8f3b0a6881fa6c92edb78e43999f9ab0
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SUSD4 EDNRB ITPKB HEG1 MCTP1 CASKIN2 CLEC14A	6.04e-06	190	161	7	a3c6eec6df052105ab78b7e3c78f94218d5912eb
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP23 WNT2B HEG1 MCTP1 CLEC14A NOS3 PKN3	6.47e-06	192	161	7	56b021c297a21dff357531f21e2464f85186106d
ToppCell	LPS-antiTNF-Endothelial-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SUSD4 EDNRB ITPKB HEG1 MCTP1 CASKIN2 CLEC14A	6.69e-06	193	161	7	02f633b016ab19bfa65bfd0cf32f000549a62148
ToppCell	LPS-antiTNF-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SUSD4 EDNRB ITPKB HEG1 MCTP1 CASKIN2 CLEC14A	6.69e-06	193	161	7	5122b1ffba42de190061be34ecdc6176f84e56a3
ToppCell	Hippocampus-Neuronal\|Hippocampus / BrainAtlas - Mouse McCarroll V32	VGF SH3BP1 CBARP PPFIA3 GPR162 SLC12A5 SLC45A1	6.92e-06	194	161	7	8aeb347b3024354c9505f4f0fddf0b843489dc6b
ToppCell	LPS-IL1RA-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SUSD4 EDNRB ITPKB HEG1 MCTP1 CASKIN2 CLEC14A	6.92e-06	194	161	7	43f92b0533e26633dc94cce554045d641ef8fd76
ToppCell	LPS-IL1RA-Endothelial-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SUSD4 EDNRB ITPKB HEG1 MCTP1 CASKIN2 CLEC14A	6.92e-06	194	161	7	1d39d968730a7e85b6161c1c8a6bd38afe9bcad7
ToppCell	LA-09._Endothelium_I\|World / Chamber and Cluster_Paper	WNT2B ITPKB HEG1 MCTP1 CLEC14A NOS3 PKN3	7.16e-06	195	161	7	fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-2\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	CACNA1C TRNP1 SPEG BRSK2 ARTN EDNRB TBX2	8.17e-06	199	161	7	471738f2059e20407572d9c4cbd11812068333ea
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-2\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	CACNA1C TRNP1 SPEG BRSK2 ARTN EDNRB TBX2	8.17e-06	199	161	7	706b7de777ff86eb22e538ccd5c2987ceb6be308
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-2-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CACNA1C TRNP1 SPEG BRSK2 ARTN EDNRB TBX2	8.17e-06	199	161	7	690a4f84b205532c4c9e5c19d5ae430d0655f421
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW26\|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type.	ARHGAP23 OBSCN BCAN SRCIN1 EDNRB SHC2 AGAP2	8.45e-06	200	161	7	61d7dd0a78942b069c3f5e75044368dc00e6e8e6
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW10-Macroglial-Astrocyte\|GW10 / Sample Type, Dataset, Time_group, and Cell type.	BICRA COL27A1 EDNRB HEG1 ZNRF3 SCRIB NOS3	8.45e-06	200	161	7	98a994692440cb4f505b050276f0c8022c814a21
ToppCell	Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid-Megakaryocyte\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CCDC117 BCL2L11 MBD6 CSF1 YLPM1 RITA1 MAST3	8.45e-06	200	161	7	0d76b006d8e8b32174e65e400acd0674354b962c
ToppCell	Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CCDC117 BCL2L11 MBD6 CSF1 YLPM1 RITA1 MAST3	8.45e-06	200	161	7	cc8368665bc6bb7c4f39632ccff07ceaa98a7b65
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW10-Macroglial\|GW10 / Sample Type, Dataset, Time_group, and Cell type.	BICRA COL27A1 EDNRB HEG1 ZNRF3 SCRIB NOS3	8.45e-06	200	161	7	ef222dc4a205d670172dae74990bdb952ac92e5b
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW26\|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type.	ARHGAP23 OBSCN BCAN SRCIN1 EDNRB SHC2 AGAP2	8.45e-06	200	161	7	5c7263c862093ad9dbc81d06b16b6f74e8a6b634
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	RSPH4A WNT2B RADIL HEG1 MCTP1 CLEC14A	1.79e-05	150	161	6	322aa0c3fc159a4b2897daac881dfc744b24ffc4
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DUSP8 CPNE5 HEG1 CLEC14A NOS3 PKN3	1.86e-05	151	161	6	3b4c57bad61e17a573e6f8dc6b917fba5fd56c43
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	XRCC1 CHAMP1 CCDC61 PRKCG APBB1IP ARAP1	1.86e-05	151	161	6	b698ddc74565d47892c09c3f16d78038da2dd5e7
ToppCell	Mild_COVID-19-Myeloid-TRAM2\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	C19orf47 WWC2-AS2 PDZD7 SSC5D DENND4B PKN3	2.07e-05	154	161	6	ab648f6b29eb9e499e46cbdbaf3c5cf6b94d1f64
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-3\|TCGA-Colorectal / Sample_Type by Project: Shred V9	GPR137 SCARF2 LRFN3 FAAP100 CCDC61 TBX2	2.23e-05	156	161	6	b464871ad7c8ce0d58013a27996639eac1e526d8
ToppCell	Adult-Endothelial-endothelial_cell_of_artery-D122\|Adult / Lineage, Cell type, age group and donor	SPEG WNT2B HEG1 CLEC14A NOS3 PKN3	3.38e-05	168	161	6	8c3e1e45b422813bcdfa4273b1167db649a312f5
ToppCell	droplet-Kidney-KIDNEY-1m-Myeloid-nan\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DDX31 P3H3 SH3BP1 BCOR GPR162 ARAP1	3.74e-05	171	161	6	d9ad6a3bce3556abd24af1630bf4a99594437c3a
ToppCell	facs-Heart-LV-3m-Endothelial-endothelial_cell_of_endocardium\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGFBR3L GPR162 EDNRB HEG1 TMEM108 NOS3	3.86e-05	172	161	6	f2c17c49b375b28ad47dc6cabda62f1c238023dd
ToppCell	facs-Heart-LV-3m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGFBR3L GPR162 EDNRB HEG1 TMEM108 NOS3	3.86e-05	172	161	6	6ab4f01098dddb789df298ddf97b3c384405ee6c
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DDX31 NTSR2 ANKLE1 TESK1 WNK2 ARHGAP33	3.99e-05	173	161	6	8bffd512a4e561e23cc04478e2ca6fd5d3771fe4
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DDX31 NTSR2 ANKLE1 TESK1 WNK2 ARHGAP33	3.99e-05	173	161	6	3e3c61468e703330788a10d850ef41a85680f86d
ToppCell	CV-Mild-6\|Mild / Virus stimulation, Condition and Cluster	USP36 BCL2L11 PSKH1 BCAN FAM157B ARHGAP33	4.25e-05	175	161	6	c4d530dbb37942427c9cd0a1533faeb6a3a45381
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CPNE5 MCTP1 SHC2 CLEC14A NOS3 PKN3	4.39e-05	176	161	6	1df7b6ce2519ad99bacbbaf1a8d5929e11513faa
ToppCell	E17.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	OBSCN TRIOBP EDNRB CLEC14A NOS3 PKN3	4.67e-05	178	161	6	0139b42494c1186390b12106dea7957e2b6717c2
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Hematologic-hematopoietic_stem_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN ARHGAP23 COL27A1 CAPN3 DOK2 GPR162	4.67e-05	178	161	6	d9eba884e18a0c89bdc70c194bfe4d62cca164fa
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Hematologic-hematopoietic_stem_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN ARHGAP23 COL27A1 CAPN3 DOK2 GPR162	4.67e-05	178	161	6	b03aa1de9d20895ebad55f6fcd6fe7a49335db5a
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Hematologic\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN ARHGAP23 COL27A1 CAPN3 DOK2 GPR162	4.67e-05	178	161	6	0f5cf34609df791c8baebfdc6590f6eb4dbe0509
ToppCell	367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)\|367C / Donor, Lineage, Cell class and subclass (all cells)	EDNRB CASKIN2 CLEC14A MARVELD2 PKN3 TBX2	4.97e-05	180	161	6	162cec1734e560c068cd61717e40e18dcf92308c
ToppCell	367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	EDNRB CASKIN2 CLEC14A MARVELD2 PKN3 TBX2	4.97e-05	180	161	6	33c86c22ba877358cd8c1e39b5c0b3dc3a45b7dd
ToppCell	facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRAF3IP2 FRAT1 E2F1 SSC5D RADIL SHC2	5.13e-05	181	161	6	c7f5aedcb74c21fb587a95a16d700e2a38a380ee
ToppCell	RA-07._Pericyte\|RA / Chamber and Cluster_Paper	CACNA1C RGL3 COL27A1 APBB2 ARHGEF17 TBX2	5.13e-05	181	161	6	8dfb42d096db6c2df9b41303a7199d134d4bff07
ToppCell	PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	GPR137 BCL2L11 APBB2 CCDC61 MCTP1 UTF1	5.13e-05	181	161	6	2b9b460239d67fd480cee60820cdb306109d3567
ToppCell	COVID-19-Heart-Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA1C COL27A1 ARHGEF17 EDNRB AGAP2 TBX2	5.13e-05	181	161	6	33cac65ed1ea5e7bd72250495df4f850b143d5aa
ToppCell	facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRAF3IP2 FRAT1 E2F1 SSC5D RADIL SHC2	5.13e-05	181	161	6	0ec9621a078d004bbd25a587757d24b5cf162959
ToppCell	PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	GPR137 BCL2L11 APBB2 CCDC61 MCTP1 UTF1	5.13e-05	181	161	6	2a1aa4a0ec7bc367857beaff543135e4345c835b
ToppCell	RA-07._Pericyte\|World / Chamber and Cluster_Paper	CACNA1C RGL3 COL27A1 APBB2 ARHGEF17 TBX2	5.29e-05	182	161	6	2075efeae633550fb2eb026d0dfd741c8252482e
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP23 PABPC1 PLCH2 TNS4 MTCL1 WNK2	5.29e-05	182	161	6	678eadd57e7e830fc2bf9fd35616d3badce01705
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP23 PABPC1 PLCH2 TNS4 MTCL1 WNK2	5.29e-05	182	161	6	8d1229fa5aa6e2e38f2ac6fe4f4dc89752fe9344
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RTKN HEG1 CLEC14A WFIKKN1 PKN3 TBX2	5.45e-05	183	161	6	ce8be9418b473ea94ec806edc7a2078cc30c1703
ToppCell	wk_08-11-Hematologic_Lymphocytic-NK-Cycling_NK\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	IL16 CAPN3 DOK2 FCHO1 TNS4 APBB1IP	5.45e-05	183	161	6	19652ca16989cb0be7d444cb5bf209b32d163bdb
ToppCell	LV-07._Pericyte\|World / Chamber and Cluster_Paper	RGL3 COL27A1 APBB2 ARHGEF17 AGAP2 TBX2	5.45e-05	183	161	6	273db6a3b00a93ca852498471187b642b5368185
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ARHGAP23 RTKN RADIL SHC2 NOS3 PKN3	5.45e-05	183	161	6	bc98df870de65aff6dab295c24cbc199c7f2aa15
ToppCell	droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	AMPH COL27A1 LRFN3 PLEKHA4 ARHGEF17 KIFC2	5.62e-05	184	161	6	e33e2a887aafba7b6a31f00bb0dbe974b4359fd6
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	AMPH FCHO2 PABPC1 EHBP1L1 SRRM2 ARAP1	5.62e-05	184	161	6	bc0dfe29337f02594e7e0092c9e47dda94b45ad5
ToppCell	facs-Heart-LA-18m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EDNRB HEG1 CLEC14A TMEM108 NOS3 PKN3	5.79e-05	185	161	6	1ecfca049c0c1110fd1b2256db7cb7abda6afb04
ToppCell	facs-Heart-LA-18m-Endothelial-endothelial_cell_of_endocardium\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EDNRB HEG1 CLEC14A TMEM108 NOS3 PKN3	5.79e-05	185	161	6	b6df1412b579d40ed5df806f9c54bd1fbb9a1e15
ToppCell	LV-07._Pericyte\|LV / Chamber and Cluster_Paper	RGL3 COL27A1 APBB2 ARHGEF17 AGAP2 TBX2	5.79e-05	185	161	6	acb38eba871ec72f2a8136a33b87d33b8c85465d
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-interneuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL16 BRSK2 MCTP1 PLCH2 C1QTNF4 MTCL1	5.96e-05	186	161	6	d1d01ce46e62944aa9864eda47e8401b5f0d2bdc
ToppCell	droplet-Heart-nan-3m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FCHO2 EDNRB ITPKB HEG1 CLEC14A NOS3	5.96e-05	186	161	6	0ae5fbe9f210cb25092394267e1d3d6ed05627b8
ToppCell	RV-07._Pericyte\|RV / Chamber and Cluster_Paper	RGL3 COL27A1 APBB2 ARHGEF17 AGAP2 TBX2	5.96e-05	186	161	6	c533b264fbe12bc35467486fc7fbde24ba968fe1
ToppCell	3'-Adult-LargeIntestine-Mesenchymal-Pericytes-Pericyte\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SCARF2 ARHGEF17 EDNRB C1QTNF4 AGAP2 TBX2	6.14e-05	187	161	6	150023e6a50c9da461f2321074d2d5e96caafb06
ToppCell	3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-2\|lymph-node_spleen / Manually curated celltypes from each tissue	FNDC3B PCNX3 TRIOBP BCOR PRR19 UTF1	6.14e-05	187	161	6	3c10b8501226c69d71bcd99dc1c064a3c2154f87
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA1C OBSCN ARHGEF17 SLC6A5 WNK2 TBX2	6.14e-05	187	161	6	86250acf088ec0c4800a0dfa031b0d4f7e52c342
ToppCell	droplet-Kidney-nan-3m-Epithelial-Pecam____Kidney_cortex_artery_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN ARHGAP23 DUSP8 HEG1 NOS3 PKN3	6.33e-05	188	161	6	ec0e241de2c8310b4417b9d4e2420d7a1662f1c0
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP23 MCTP1 CASKIN2 CLEC14A NOS3 PKN3	6.33e-05	188	161	6	a37edd8f9e4a4e336b5acbb0407d3d275975cee8
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|Adult / Lineage, Cell type, age group and donor	OBSCN EDNRB SHC2 CASKIN2 PKN3 TBX2	6.33e-05	188	161	6	e5cad03f4a64147fe8174e7f614cf45233ffb9b7
ToppCell	Bronchial-10x5prime-Stromal-Schwann-Schwann_nonmyelinating\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	RTKN ARHGEF17 EDNRB MICALL2 C1QTNF4	6.42e-05	116	161	5	b0a3c109c5f20ab699e53bf8ab3903d102f5f315
ToppCell	droplet-Heart-nan-3m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OTUD1 PABIR2 EDNRB HEG1 TMEM108 NOS3	6.52e-05	189	161	6	8e583ec4df0f5b79ce5211cc99ecd8616d180bde
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Epithelial\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RALGDS CBARP TESK1 PABPC1 PLCH2 KIF1C	6.52e-05	189	161	6	965e0e388251e7318f8b463816dc96ccb4658677
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FNDC3B SUSD4 RGL3 APBB2 ITPKB TMEM108	6.52e-05	189	161	6	975c0f079903ae36b0ffa54e86294d42ec7697de
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	APBB2 EDNRB HEG1 MCTP1 CLEC14A NOS3	6.52e-05	189	161	6	9da012fdfa9a8d488cab710a463a1d70e89f990c
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FNDC3B SUSD4 RGL3 APBB2 ITPKB TMEM108	6.52e-05	189	161	6	7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917
ToppCell	droplet-Heart-nan-3m-Endothelial-endocardial_endothelial_cells\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OTUD1 PABIR2 EDNRB HEG1 TMEM108 NOS3	6.52e-05	189	161	6	fb2253b8463d08b3d28e952a31a23dea2c2d986b
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	WNT2B OBSCN EDNRB CASKIN2 PKN3 TBX2	6.71e-05	190	161	6	0a351609a72fd638c84b2435782e312ee6a33aac
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARHGAP23 APBB2 SLC12A5 CASKIN2 CLEC14A NOS3	6.71e-05	190	161	6	d0297d678498e346e56cf95fe9e3db7d3ad3b837
Drug	2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A	GPR137 PRR36 APBB2 ARTN PPFIA3 SLC12A5 EHBP1L1 CSF1 CROCC SRRM2 BBC3 ARHGAP33 KIF1C	1.13e-09	199	155	13	5219_UP
Drug	16, 16-dimethylprostaglandin E2 methyl acetate solution; Up 200; 10uM; MCF7; HT_HG-U133A	SHANK1 DDX31 PSKH1 SH3BP1 ARTN FAAP100 HEG1 CABIN1 NUP160 ARHGAP33 DNM2	1.18e-07	198	155	11	6597_UP
Drug	Minocycline hydrochloride [13614-98-7]; Down 200; 8uM; MCF7; HT_HG-U133A	RALGDS KMT2B TRIO PSKH1 E2F1 PPFIA3 CASKIN2 PLCB3 MTCL1 CABIN1 DNM2	1.25e-07	199	155	11	7436_DN
Drug	Amrinone [60719-84-8]; Down 200; 21.4uM; MCF7; HT_HG-U133A	RALGDS E2F1 PPFIA3 FCHO1 CASKIN2 FARP1 TLE3 YLPM1 MTCL1 MAST3 TBX2	1.31e-07	200	155	11	3465_DN
Drug	Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A	VGF GPR137 TRIO SH3BP1 E2F1 CASKIN2 PLCB3 INO80B MAST3 TBX2	8.59e-07	193	155	10	3262_UP
Drug	Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; PC3; HT_HG-U133A	GPR137 TRAF3IP2 TRIO P3H3 APBB2 CASKIN2 NUP160 INO80B ARAP1 KIF1C	8.59e-07	193	155	10	4338_DN
Drug	Etilefrine hydrochloride [534-87-2]; Down 200; 18.4uM; PC3; HT_HG-U133A	GPR137 KMT2B TRIO SPEG BCAN ARHGEF17 CSF1 CABIN1 ARHGAP33 TBX2	9.88e-07	196	155	10	4590_DN
Drug	Doxylamine succinate [562-10-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A	SUSD4 BCL2L11 TRIO PRR36 RTEL1 ITPKB EHBP1L1 PLCB3 INO80B ARAP1	1.04e-06	197	155	10	1473_DN
Drug	Clindamycin hydrochloride [21462-39-5]; Down 200; 8.6uM; PC3; HT_HG-U133A	LRFN3 TRIOBP E2F1 FAAP100 SLC2A10 CSF1 DCAF10 YLPM1 PLCB3 MAST3	1.04e-06	197	155	10	5815_DN
Drug	fluphenazine dihydrochloride; Up 200; 10uM; PC3; HT_HG-U133A	GPR137 RTEL1 LRFN3 ARTN XRCC1 PPFIA3 CSF1 CASKIN2 TNS4 KIF1C	1.04e-06	197	155	10	1237_UP
Drug	Colistin sulfate [1264-72-8]; Down 200; 3uM; MCF7; HT_HG-U133A	USP36 ITCH PRR36 FRAT1 APBB2 TRIOBP ARTN EHBP1L1 ARAP1 DNM2	1.04e-06	197	155	10	4796_DN
Drug	Disopyramide [3737-09-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A	USP36 TRAF3IP2 DUSP8 PPFIA3 ITPKB SLC12A5 CROCC SRRM2 MAST3 ARAP1	1.13e-06	199	155	10	7439_UP
Drug	BiM4	IL16 BCL2L11 P3H3 GRIN2D GPR162 EDNRB PRKCG PKN1 PLCB3 NOS3 PKN3	4.01e-06	283	155	11	CID000002399
Drug	norathyriol	P3H3 GPR162 PRKCG PLCB3 PKN3	5.01e-06	37	155	5	CID005281656
Drug	17-AAG; Down 200; 1uM; PC3; HT_HG-U133A	GPR137 TRAF3IP2 PSKH1 NCKIPSD E2F1 EHBP1L1 DENND4B MAST3 ARAP1	5.87e-06	188	155	9	1218_DN
Drug	Lovastatin [75330-75-5]; Up 200; 9.8uM; MCF7; HT_HG-U133A	TRIO PRR36 RTEL1 DOK2 PPFIA3 CABIN1 BBC3 MAST3 ARAP1	7.27e-06	193	155	9	4978_UP
Drug	AC1L1KEH	BCL2L11 SLC6A5 PRKCG PLCB3 PKN3	7.44e-06	40	155	5	CID000005462
Drug	CGX 0596987; Down 200; 20uM; PC3; HT_HG-U133A	GPR137 TRAF3IP2 KMT2B BICRA E2F1 XRCC1 PPFIA3 SHC2 CABIN1	7.58e-06	194	155	9	6417_DN
Drug	Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; MCF7; HT_HG-U133A	DDX31 KMT2B BICRA XRCC1 CASKIN2 TLE3 CABIN1 SRRM2 INO80B	7.90e-06	195	155	9	3408_DN
Drug	Acacetin [480-44-4]; Down 200; 14uM; PC3; HT_HG-U133A	GPR137 TRIO ARTN YLPM1 CABIN1 NUP160 INO80B ARHGAP33 TBX2	7.90e-06	195	155	9	4324_DN
Drug	Piroxicam [36322-90-4]; Down 200; 12uM; PC3; HT_HG-U133A	UBE4B BICRA DUSP8 XRCC1 TESK1 TLE3 PLCB3 SRRM2 KIF1C	8.23e-06	196	155	9	2089_DN
Drug	Pyridoxine hydrochloride [58-56-0]; Down 200; 19.4uM; MCF7; HT_HG-U133A	VGF GPR137 TRAF3IP2 ARTN XRCC1 PPFIA3 ITPKB CASKIN2 TBX2	8.23e-06	196	155	9	2751_DN
Drug	Estradiol-17 beta [50-28-2]; Up 200; 14.6uM; MCF7; HT_HG-U133A	FNDC3B RALGDS KMT2B RTEL1 BICRA FAAP100 FCHO1 ITPKB CASKIN2	8.23e-06	196	155	9	5318_UP
Drug	Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A	VGF GPR137 MBD1 NCKIPSD YLPM1 PLCB3 INO80B DNM2 TBX2	8.23e-06	196	155	9	4826_DN
Drug	Hydrastine hydrochloride [5936-28-7]; Down 200; 9.6uM; PC3; HT_HG-U133A	DDX31 RTEL1 MBD1 APBB2 PPFIA3 MICALL2 TLE3 INO80B MAST3	8.57e-06	197	155	9	7309_DN
Drug	Doxazosin mesylate [77883-43-3]; Down 200; 7.4uM; MCF7; HT_HG-U133A	TRAF3IP2 BICRA MBD1 TRIOBP ARTN PPFIA3 TLE3 PKN1 INO80B	8.57e-06	197	155	9	4988_DN
Drug	Noscapine [128-62-1]; Down 200; 9.6uM; PC3; HT_HG-U133A	BCL2L11 BICRA SPEG APBB2 XRCC1 FAAP100 CASKIN2 SRRM2 NUP160	8.57e-06	197	155	9	5851_DN
Drug	Cefotiam hydrochloride; Down 200; 7.2uM; MCF7; HT_HG-U133A	LRFN3 MBD1 E2F1 XRCC1 PPFIA3 ATXN7 FARP1 SRRM2 INO80B	8.57e-06	197	155	9	5361_DN
Drug	Pseudopelletierine hydrochloride [6164-62-1]; Up 200; 21uM; MCF7; HT_HG-U133A	PRR36 E2F1 PPFIA3 ARHGEF17 FCHO1 SRRM2 BBC3 ARHGAP33 MAST3	8.57e-06	197	155	9	2766_UP
Drug	Suprofen [40828-46-4]; Down 200; 15.4uM; PC3; HT_HG-U133A	TRAF3IP2 RALGDS RTEL1 ARTN CASKIN2 PLCB3 CABIN1 INO80B MAST3	8.93e-06	198	155	9	4005_DN
Drug	(+) -Levobunolol hydrochloride [47141-41-3]; Up 200; 12.2uM; MCF7; HT_HG-U133A	GPR137 TRIO RTEL1 DOK2 ARTN EHBP1L1 TLE3 ARHGAP33 MAST3	8.93e-06	198	155	9	4980_UP
Drug	Acenocoumarol [152-72-7]; Down 200; 11.4uM; PC3; HT_HG-U133A	GPR137 TRAF3IP2 BCL2L11 UBE4B EHBP1L1 DCAF10 TLE3 PLCB3 NUP160	8.93e-06	198	155	9	5878_DN
Drug	Moroxidine hydrochloride [3160-91-6]; Up 200; 19.2uM; MCF7; HT_HG-U133A	USP36 IL16 SPEG APBB2 DOK2 ARHGEF17 EHBP1L1 SLC6A5 SRRM2	9.30e-06	199	155	9	1527_UP
Drug	Alverine citrate salt [5560-59-8]; Down 200; 8.4uM; MCF7; HT_HG-U133A	VGF USP36 RTEL1 APBB2 SLC12A5 PLCB3 CABIN1 ARAP1 AGAP2	9.30e-06	199	155	9	2273_DN
Drug	Iohexol [66108-95-0]; Up 200; 4.8uM; MCF7; HT_HG-U133A	GPR137 PRR36 APBB2 ARTN CSF1 TLE3 SRRM2 ARAP1 KIF1C	9.68e-06	200	155	9	3322_UP
Drug	Adiphenine hydrochloride [50-42-0]; Down 200; 11.4uM; HL60; HT_HG-U133A	GPR137 BICRA APBB2 PDZD7 FAAP100 TESK1 CSF1 PLCB3 DNM2	9.68e-06	200	155	9	1872_DN
Drug	CAY10397; Up 200; 10uM; MCF7; HT_HG-U133A	USP36 PSKH1 E2F1 ARTN EDNRB SLC12A5 EHBP1L1 CASKIN2 CABIN1	9.68e-06	200	155	9	7082_UP
Drug	Trazodone hydrochloride [25332-39-2]; Down 200; 9.8uM; MCF7; HT_HG-U133A	DDX31 FAAP100 SLC2A10 MICALL2 TLE3 YLPM1 PLCB3 SRRM2 TBX2	9.68e-06	200	155	9	7410_DN
Drug	bisindolylmaleimide II	BCL2L11 PRKCG CABIN1 PKN3	3.72e-05	28	155	4	CID000002397
Drug	A0666_sigma	RGL3 PRKCG CABIN1 NOS3 PKN3	3.96e-05	56	155	5	CID000005680
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	GPR137 APBB2 ARHGEF17 MICALL2 CASKIN2 FARP1 TLE3 INO80B	4.06e-05	185	155	8	5585_DN
Drug	15d-PGJ2; Down 200; 10uM; HL60; HT_HG-U133A	USP36 DDX31 BCL2L11 E2F1 FCHO1 SCRIB CABIN1 APBB1IP	4.39e-05	187	155	8	6190_DN
Drug	ICI 182,780; Down 200; 0.01uM; MCF7; HT_HG-U133A	GPR137 LRFN3 ARTN PPFIA3 EHBP1L1 HEG1 CABIN1 INO80B	4.39e-05	187	155	8	5598_DN
Drug	Meclozine dihydrochloride [1104-22-9]; Down 200; 8.6uM; MCF7; HT_HG-U133A	GPR137 TRAF3IP2 BCL2L11 ARTN ARHGEF17 EHBP1L1 HEG1 CABIN1	5.09e-05	191	155	8	5607_DN
Drug	Y-27632; Up 200; 3uM; MCF7; HT_HG-U133A_EA	BICRA MBD1 APBB2 PPFIA3 EHBP1L1 HEG1 MICALL2 YLPM1	5.48e-05	193	155	8	948_UP
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A	GPR137 DDX31 TRIO MBD1 PPFIA3 FAAP100 MTCL1 MAST3	5.48e-05	193	155	8	5239_DN
Drug	Dimenhydrinate [523-87-5]; Down 200; 8.6uM; MCF7; HT_HG-U133A	TRAF3IP2 APBB2 ARTN ARHGEF17 EHBP1L1 ARHGAP33 ARAP1 DNM2	5.69e-05	194	155	8	5450_DN
Drug	retinoic acid; Down 200; 1uM; PC3; HT_HG-U133A	E2F1 EHBP1L1 MCTP1 FARP1 TLE3 DENND4B YLPM1 SRRM2	5.69e-05	194	155	8	1211_DN
Drug	0173570-0000 [211245-44-2]; Down 200; 1uM; MCF7; HT_HG-U133A	VGF NCKIPSD ARTN BCOR ARHGEF17 PLCB3 BBC3 NUP160	5.69e-05	194	155	8	4715_DN
Drug	Enalapril maleate [76095-16-4]; Down 200; 8.2uM; HL60; HT_HG-U133A	GPR137 RALGDS BCL2L11 PDZD7 TESK1 PLCB3 INO80B ARAP1	5.69e-05	194	155	8	2397_DN
Drug	Loxapine succinate [27833-64-3]; Up 200; 9uM; MCF7; HT_HG-U133A	ITCH BCOR FCHO1 ITPKB PLCB3 NUP160 INO80B ARHGAP33	5.69e-05	194	155	8	5293_UP
Drug	Alexidine dihydrochloride [22573-93-9]; Down 200; 6.8uM; MCF7; HT_HG-U133A	RALGDS PPFIA3 EHBP1L1 YLPM1 PLCB3 SRRM2 INO80B ARAP1	5.69e-05	194	155	8	4721_DN
Drug	Trihexyphenidyl-D,L Hydrochloride [58947-95-8]; Up 200; 11.8uM; PC3; HT_HG-U133A	VGF TRIO PPFIA3 FAAP100 HEG1 BBC3 ARHGAP33 KIF1C	5.69e-05	194	155	8	4015_UP
Drug	Dapsone [80-08-0]; Down 200; 16.2uM; PC3; HT_HG-U133A	GPR137 DDX31 PPFIA3 CASKIN2 PLCB3 NUP160 INO80B ARAP1	5.89e-05	195	155	8	5078_DN
Drug	Securinine [5610-40-2]; Down 200; 18.4uM; MCF7; HT_HG-U133A	RALGDS APBB2 E2F1 PPFIA3 SLC2A10 YLPM1 PLCB3 MAST3	5.89e-05	195	155	8	3470_DN
Drug	Ofloxacin [82419-36-1]; Up 200; 11uM; PC3; HT_HG-U133A	GPR137 DDX31 KMT2B FAAP100 TESK1 CASKIN2 NUP160 TBX2	5.89e-05	195	155	8	7372_UP
Drug	Hesperetin [520-33-2]; Up 200; 13.2uM; MCF7; HT_HG-U133A	USP36 RTEL1 E2F1 CASKIN2 PKN1 CABIN1 BBC3 KIF1C	6.11e-05	196	155	8	5350_UP
Drug	(-)-Cinchonidine [485-71-2]; Down 200; 13.6uM; PC3; HT_HG-U133A	GPR137 DDX31 DUSP8 APBB2 FAAP100 ITPKB HEG1 PLCB3	6.11e-05	196	155	8	5833_DN
Drug	Norfloxacin [70458-96-7]; Down 200; 12.6uM; PC3; HT_HG-U133A	BICRA DUSP8 TLE3 PLCB3 INO80B ARAP1 TBX2 KIF1C	6.11e-05	196	155	8	2090_DN
Drug	GSK-3 Inhibitor IX; Up 200; 0.5uM; PC3; HT_HG-U133A	RTEL1 P3H3 APBB2 TRIOBP CASKIN2 SRRM2 BBC3 TBX2	6.11e-05	196	155	8	6559_UP
Drug	Pempidine tartrate [546-48-5]; Up 200; 13uM; PC3; HT_HG-U133A	GPR137 KMT2B DOK2 ARHGEF17 SLC12A5 PLCH2 BBC3 INO80B	6.11e-05	196	155	8	4307_UP
Drug	Aceclofenac [89796-99-6]; Down 200; 11.2uM; MCF7; HT_HG-U133A	VGF GPR137 UBE4B LRFN3 ARTN PPFIA3 BBC3 KIF1C	6.11e-05	196	155	8	7029_DN
Drug	genistein; Up 200; 10uM; MCF7; HT_HG-U133A	TRIO PRR36 LRFN3 ARTN PLCB3 SRRM2 ARAP1 KIF1C	6.11e-05	196	155	8	5232_UP
Drug	Fenofibrate [49562-28-9]; Up 200; 11uM; MCF7; HT_HG-U133A	GPR137 TRIO PRR36 ARTN PPFIA3 BCOR EHBP1L1 BBC3	6.11e-05	196	155	8	7432_UP
Drug	Hydrastine hydrochloride [5936-28-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A	KMT2B RTEL1 DUSP8 E2F1 ARTN ITPKB FARP1 MAST3	6.11e-05	196	155	8	2889_DN
Drug	Trifluridine [70-00-8]; Down 200; 13.6uM; PC3; HT_HG-U133A	CENPA PPFIA3 HEG1 TLE3 YLPM1 PLCB3 MAST3 KIF1C	6.33e-05	197	155	8	5819_DN
Drug	Diazoxide [364-98-7]; Down 200; 17.4uM; PC3; HT_HG-U133A	TRAF3IP2 TRIO RTEL1 SLC2A10 CSF1 PKN1 PLCB3 MAST3	6.33e-05	197	155	8	5810_DN
Drug	Norethindrone [68-22-4]; Down 200; 13.4uM; PC3; HT_HG-U133A	GPR137 TRIO DUSP8 APBB2 PPFIA3 PLCB3 NUP160 DNM2	6.33e-05	197	155	8	5055_DN
Drug	Mycophenolic acid [24280-93-1]; Down 200; 12.4uM; MCF7; HT_HG-U133A	GPR137 KMT2B CENPA MBD1 APBB2 ARTN ITPKB PLCB3	6.33e-05	197	155	8	4137_DN
Drug	Pindolol [13523-86-9]; Up 200; 16.2uM; PC3; HT_HG-U133A	GPR137 RTEL1 ITPKB SLC2A10 EHBP1L1 MCTP1 CASKIN2 ARAP1	6.33e-05	197	155	8	2075_UP
Drug	celecoxib; Down 200; 10uM; MCF7; HT_HG-U133A_EA	VGF UBE4B PSKH1 MBD1 ARTN TESK1 MAST3 ARAP1	6.33e-05	197	155	8	922_DN
Drug	Sulfaguanidine [57-67-0]; Down 200; 18.6uM; MCF7; HT_HG-U133A	E2F1 ARTN PPFIA3 EHBP1L1 CASKIN2 CABIN1 INO80B ARAP1	6.33e-05	197	155	8	1495_DN
Drug	Sulfadiazine [68-35-9]; Down 200; 16uM; PC3; HT_HG-U133A	PRR36 FRAT1 BICRA PPFIA3 CSF1 NUP160 MAST3 ARAP1	6.33e-05	197	155	8	1810_DN
Drug	Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; MCF7; HT_HG-U133A	PRR36 RTEL1 BICRA ARTN ITPKB EHBP1L1 CSF1 INO80B	6.33e-05	197	155	8	3829_DN
Drug	Etilefrine hydrochloride [534-87-2]; Down 200; 18.4uM; MCF7; HT_HG-U133A	GPR137 RTEL1 ARTN PPFIA3 FCHO1 ITPKB SRRM2 KIF1C	6.33e-05	197	155	8	7350_DN
Drug	Glycopyrrolate [596-51-0]; Down 200; 10uM; MCF7; HT_HG-U133A	VGF TRAF3IP2 PRR36 APBB2 ARTN SLC12A5 EHBP1L1 ARHGAP33	6.33e-05	197	155	8	4709_DN
Drug	Ajmalicine hydrochloride [4373-34-6]; Down 200; 10.2uM; PC3; HT_HG-U133A	UBE4B E2F1 PPFIA3 MICALL2 FARP1 PLCB3 MAST3 DNM2	6.33e-05	197	155	8	6360_DN
Drug	Carbarsone [121-59-5]; Down 200; 15.4uM; MCF7; HT_HG-U133A	RALGDS E2F1 FAAP100 CASKIN2 MTCL1 SRRM2 INO80B KIF1C	6.33e-05	197	155	8	3250_DN
Drug	Nimesulide [51803-78-2]; Down 200; 13uM; MCF7; HT_HG-U133A	VGF PSKH1 APBB2 ARTN ITPKB MICALL2 PLCB3 ARAP1	6.33e-05	197	155	8	2275_DN
Drug	Trichlormethiazide [133-67-5]; Down 200; 10.6uM; HL60; HT_HG-U133A	RALGDS CAPN3 PDZD7 HEG1 TLE3 NUP160 INO80B APBB1IP	6.33e-05	197	155	8	2998_DN
Drug	Lorglumide sodium salt [97964-56-2]; Down 200; 8.4uM; MCF7; HT_HG-U133A	ITCH KMT2B MICALL2 CASKIN2 PLCB3 ARHGAP33 ARAP1 DNM2	6.33e-05	197	155	8	6456_DN
Drug	Go7874	AMPH PKN1 DNM2	6.51e-05	12	155	3	CID005327863
Drug	Tomatidine [77-59-8]; Down 200; 9.6uM; MCF7; HT_HG-U133A	USP36 DDX31 ARTN FAAP100 FARP1 SRRM2 NUP160 MAST3	6.56e-05	198	155	8	7166_DN
Drug	Pentolinium bitartrate [52-62-0]; Up 200; 7.4uM; PC3; HT_HG-U133A	BCL2L11 TRIO RTEL1 E2F1 EDNRB CSF1 YLPM1 CABIN1	6.56e-05	198	155	8	7375_UP
Drug	Isoflupredone acetate [338-98-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A	RTEL1 LRFN3 ARTN HEG1 BBC3 INO80B ARHGAP33 MAST3	6.56e-05	198	155	8	5545_DN
Drug	Testosterone propionate [57-85-2]; Up 200; 11.6uM; MCF7; HT_HG-U133A	TRAF3IP2 PRR36 RTEL1 DOK2 EHBP1L1 PLCH2 EPS8L3 ARHGAP33	6.56e-05	198	155	8	2649_UP
Drug	Oxprenolol hydrochloride [6452-73-9]; Down 200; 13.2uM; PC3; HT_HG-U133A	DDX31 BCL2L11 BICRA APBB2 E2F1 FAAP100 NUP160 TBX2	6.56e-05	198	155	8	5871_DN
Drug	Minoxidil [38304-91-5]; Down 200; 19.2uM; MCF7; HT_HG-U133A	GPR137 PRR36 BICRA PPFIA3 EHBP1L1 FARP1 ARHGAP33 ARAP1	6.56e-05	198	155	8	4800_DN
Drug	cox-2 inhibitor I; Down 200; 10uM; MCF7; HG-U133A	SUSD4 UBE4B PDZD7 ARTN ITPKB MICALL2 CASKIN2 RITA1	6.56e-05	198	155	8	612_DN
Drug	Homatropine hydrobromide (R,S) [51-56-9]; Up 200; 11.2uM; PC3; HT_HG-U133A	RALGDS KMT2B MBD1 ARTN HEG1 FARP1 CABIN1 INO80B	6.56e-05	198	155	8	1806_UP
Drug	Metronidazole [443-48-1]; Down 200; 23.4uM; PC3; HT_HG-U133A	RTEL1 E2F1 EHBP1L1 CSF1 ATXN7 SRRM2 INO80B ARAP1	6.56e-05	198	155	8	4023_DN
Drug	Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; PC3; HT_HG-U133A	GPR137 TRAF3IP2 TRIO BICRA ARTN MICALL2 INO80B ARAP1	6.56e-05	198	155	8	2096_DN
Drug	Methyldopate hydrochloride [2508-79-4]; Up 200; 14.6uM; MCF7; HT_HG-U133A	GPR137 PSKH1 DUSP8 DOK2 CASKIN2 TLE3 EPS8L3 ARHGAP33	6.80e-05	199	155	8	4986_UP
Drug	Zalcitabine [7481-89-2]; Down 200; 19uM; MCF7; HT_HG-U133A	GPR137 PRR36 MBD1 FAAP100 CASKIN2 CABIN1 INO80B ARAP1	6.80e-05	199	155	8	4799_DN
Drug	Chenodiol [474-25-9]; Down 200; 10.2uM; MCF7; HT_HG-U133A	DDX31 KMT2B TRIOBP E2F1 TLE3 YLPM1 PLCB3 CABIN1	6.80e-05	199	155	8	7433_DN
Drug	Iobenguane sulfate; Up 200; 10.8uM; HL60; HG-U133A	KMT2B UBE4B E2F1 YLPM1 NPAP1 RITA1 BBC3 ARHGAP33	6.80e-05	199	155	8	1729_UP
Drug	Vinpocetine [42971-09-5]; Down 200; 11.4uM; PC3; HT_HG-U133A	RALGDS DDX31 RTEL1 MBD1 APBB2 FAAP100 TESK1 CASKIN2	6.80e-05	199	155	8	5859_DN
Drug	alpha-estradiol; Down 200; 0.01uM; PC3; HT_HG-U133A	GPR137 TRAF3IP2 APBB2 E2F1 ARTN PPFIA3 YLPM1 PLCB3	6.80e-05	199	155	8	1210_DN
Drug	Biperiden hydrochloride [1235-82-1]; Up 200; 11.4uM; MCF7; HT_HG-U133A	GPR137 USP36 TRIO CBARP EHBP1L1 CSF1 PLCB3 KIF1C	6.80e-05	199	155	8	5279_UP
Drug	Cefoxitin sodium salt [33564-30-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A	RALGDS LRFN3 E2F1 FCHO1 CASKIN2 FARP1 YLPM1 MAST3	7.04e-05	200	155	8	3477_DN
Disease	Malignant neoplasm of breast	FNDC3B SCARF2 OBSCN E2F1 ARTN GRIN2D TESK1 PABPC1 EDNRB SLC2A10 KMT2D CSF1 FARP1 TLE3 SLC6A5 NOS3 AGAP2	2.93e-05	1074	148	17	C0006142
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	KMT2B TRIO SRRM2	7.99e-05	17	148	3	DOID:0060307 (is_implicated_in)
Disease	hypertension	VTN RGL3 WNT2B PLCB3 BAG6 NOS3 NUP160 TBX2	1.68e-04	307	148	8	EFO_0000537
Disease	prostate cancer (is_implicated_in)	IL16 RTEL1 XRCC1 NOS3 AGAP2	3.17e-04	117	148	5	DOID:10283 (is_implicated_in)
Disease	corpus callosum mid-anterior volume measurement	DUSP8 BRSK2 ZDHHC5	3.31e-04	27	148	3	EFO_0010297
Disease	hepatopulmonary syndrome (biomarker_via_orthology)	EDNRB NOS3	3.70e-04	6	148	2	DOID:900 (biomarker_via_orthology)
Disease	response to vitamin	P3H3 GPR162	6.86e-04	8	148	2	GO_0033273
Disease	colorectal adenocarcinoma (is_implicated_in)	IL16 KMT2B XRCC1	7.19e-04	35	148	3	DOID:0050861 (is_implicated_in)
Disease	Duchenne muscular dystrophy (implicated_via_orthology)	CACNA1C CAPN3 SLC6A5	7.82e-04	36	148	3	DOID:11723 (implicated_via_orthology)
Disease	transient cerebral ischemia (biomarker_via_orthology)	MBD1 XRCC1 BBC3 NOS3 WNK2	1.20e-03	157	148	5	DOID:224 (biomarker_via_orthology)
Disease	high grade glioma (is_marker_for)	E2F1 BCAN NOS3	1.23e-03	42	148	3	DOID:3070 (is_marker_for)
Disease	gastric adenocarcinoma (is_implicated_in)	RTEL1 KMT2D	1.33e-03	11	148	2	DOID:3717 (is_implicated_in)
Disease	Mammary Carcinoma, Human	E2F1 ARTN PABPC1 EDNRB SLC2A10 KMT2D CSF1 TLE3 NOS3	1.38e-03	525	148	9	C4704874
Disease	Mammary Neoplasms, Human	E2F1 ARTN PABPC1 EDNRB SLC2A10 KMT2D CSF1 TLE3 NOS3	1.38e-03	525	148	9	C1257931
Disease	Mammary Neoplasms	E2F1 ARTN PABPC1 EDNRB SLC2A10 KMT2D CSF1 TLE3 NOS3	1.42e-03	527	148	9	C1458155
Disease	cup-to-disc ratio measurement	CCDC117 WNT2B NCKIPSD TRIOBP EHBP1L1 CSF1 ZNRF3 MTCL1	1.52e-03	430	148	8	EFO_0006939
Disease	stomach carcinoma (is_implicated_in)	XRCC1 BCOR	1.60e-03	12	148	2	DOID:5517 (is_implicated_in)
Disease	Breast Carcinoma	E2F1 ARTN PABPC1 EDNRB SLC2A10 KMT2D CSF1 TLE3 NOS3	1.63e-03	538	148	9	C0678222
Disease	corpus callosum volume measurement	BRSK2 ZDHHC5 C1QTNF4 WNK2	1.64e-03	100	148	4	EFO_0010299
Disease	cryptic phenotype measurement	RGL3 WNT2B NOS3	1.71e-03	47	148	3	EFO_0021487
Disease	DEAFNESS, AUTOSOMAL RECESSIVE (disorder)	TRIOBP PDZD7	1.88e-03	13	148	2	C1846647
Disease	pancreatic carcinoma	WNT2B DOK2 ZNRF3 PKN1 TNS4	1.89e-03	174	148	5	EFO_0002618
Disease	Autosomal Recessive Centronuclear Myopathy	SPEG DNM2	2.51e-03	15	148	2	C3645536
Disease	nervousness	YLPM1 NUP160	2.86e-03	16	148	2	NCIT_C74532
Disease	Huntington's disease (biomarker_via_orthology)	E2F1 NOS3	2.86e-03	16	148	2	DOID:12858 (biomarker_via_orthology)
Disease	von Willebrand factor measurement, coronary artery disease	DDX31 FCHO2 FCHO1 NOS3	3.00e-03	118	148	4	EFO_0001645, EFO_0004629
Disease	Sjogren's syndrome (implicated_via_orthology)	TRAF3IP2 E2F1	3.23e-03	17	148	2	DOID:12894 (implicated_via_orthology)
Disease	obsolete_red blood cell distribution width	CCDC117 USP36 FNDC3B RALGDS KMT2B ARHGAP23 C19orf47 FCHO2 EHBP1L1 ZNRF3 ATXN7 YLPM1 NUTM2F MAST3 DNM2	3.24e-03	1347	148	15	EFO_0005192
Disease	Gastric ulcer	VGF NOS3	3.63e-03	18	148	2	C0038358
Disease	mean arterial pressure	USP36 PCNX3 RGL3 WNT2B ZNRF3 NOTO NOS3 TBX2	3.80e-03	499	148	8	EFO_0006340
Disease	portal hypertension (implicated_via_orthology)	EDNRB NOS3	4.04e-03	19	148	2	DOID:10762 (implicated_via_orthology)
Disease	Calcium channel blocker use measurement	CACNA1C RGL3 WNT2B NOS3 TBX2	4.49e-03	213	148	5	EFO_0009930
Disease	calcium measurement	FCHO2 PABPC1 ITPKB EHBP1L1 CASKIN2 TLE3 C1QTNF4 PKN3 TBX2	4.54e-03	628	148	9	EFO_0004838
Disease	sex interaction measurement, cerebral amyloid angiopathy	ARHGAP23 SRCIN1	4.93e-03	21	148	2	EFO_0006790, EFO_0008343

Protein segments in the cluster

Peptide	Gene	Start	Entry
DTEPPAAPARPRSPR	CBARP	516	Q8N350
TPAPPAGAARPARAP	CBARP	601	Q8N350
LAPRPGPRAVPSSPA	CCDC117	41	Q8IWD4
PPVQPPPTREDRASS	CCDC61	286	Q9Y6R9
PPPPPADSVTRRVTT	APBB2	721	Q92870
PLLDRSPAHSPPRTP	ANKLE1	296	Q8NAG6
SLNHDSPPSTPPRRP	C19orf47	146	Q8N9M1
GPAPPPATSHPRVIR	BAG6	431	P46379
RPRPPAGSPARSPAH	DUSP8	456	Q13202
PQPAPRPAPGRSSAL	BBC3	116	Q96PG8
SVGTIVPPPRPASRP	FCHO2	456	Q0JRZ9
RRSPASPSPASPGPA	SH3BP1	636	Q9Y3L3
LPPPPPVRRSSDTSG	APBB1IP	516	Q7Z5R6
ARGPPAPPEPRSAFS	C1QTNF4	166	Q9BXJ3
PAERPPQLRPGAPTS	BCL2L11	21	O43521
APASPARPVSPAPGR	AGAP2	96	Q99490
RTAGSPPRTISPPPC	EDNRB	76	P24530
SPRPSPRVHLPTQPA	BCOR	336	Q6W2J9
LAPASPAPARPRSPS	AMPH	281	P49418
PGSATTRPFIPPRQP	RBM33	546	Q96EV2
SRAPPARTVGPPTPA	MTCL1	166	Q9Y4B5
SDREPPRGAPTPSPA	MTCL1	241	Q9Y4B5
PSKDPSPEPPSRRHQ	P3H3	706	Q8IVL6
PGAIRPAAPRPPFST	PABPC1	451	P11940
PTPALGDARSSPPPR	RADIL	196	Q96JH8
SPEPPTSPRAPREEG	ARHGEF17	326	Q96PE2
RPPRVHGPPTETLPT	BCAN	531	Q96GW7
SPPSCRAPPPEARGI	FCHO1	501	O14526
PAPAAPVPPRRGSSA	OTUD1	151	Q5VV17
HTVSPGPPSARPPCR	MBD6	136	Q96DN6
PASLPRPDSPYSRPH	DOK2	261	O60496
RPDSPYSRPHDSLPP	DOK2	266	O60496
PPAEPARSPAESRAP	MCTP1	216	Q6DN14
REVPAAESPSPPHSP	MAGEA12	51	P43365
PRPPRPSSNPGLSLD	NTSR2	6	O95665
SPTASPGHSPRRPRP	GPR162	516	Q16538
PHPRSGDPSAPPRLA	SLC2A10	376	O95528
TTTVSTPPHRRDPPP	GPR137	351	Q96N19
PGDTPPPTPRSARLE	PPFIA3	711	O75145
RSPAPREGPPPVLAS	ARTN	46	Q5T4W7
PTAGHTEPPSEPPRR	PSKH1	66	P11801
SSPRVTPHPSPRGSP	BRSK2	426	Q8IWQ3
TAGPPDPPRAARPSS	CCDC120	411	Q96HB5
TEPHPRALAPSPPAE	MBD1	301	Q9UIS9
RPASPGPSLPARSPS	MICALL2	646	Q8IY33
PPASPIPTEGPRTSR	PCNX3	1906	Q9H6A9
PRAPEHPAPPATAVR	FAM157A	181	C9JC47
VVRVPGPSPRPSPSD	PDZD7	946	Q9H5P4
GADATHPPPPARSPR	DCAF10	41	Q5QP82
FTLPPPRRSSSPEDP	EPS8L3	221	Q8TE67
SPPLPESRDSHPPLR	IL16	566	Q14005
RSPAPRSPTGPNTPR	NOTO	26	A8MTQ0
PAPVSAPAPPARTSR	EHBP1L1	246	Q8N3D4
ATARPRAPEHPAPPA	FAM157C	181	P0CG43
PEEVTPHPATPARRP	KIF1C	1006	O43896
TRYPTRAPSGPRPPS	HRES1	11	P13985
RPDSGSAPPPAPRSF	KMT2B	1846	Q9UMN6
VHPDARSPTSPVPVP	PRKCG	681	P05129
PAPPAPEPAALRAHT	LRFN3	596	Q9BTN0
AAPGTRDPPPSPARR	HEG1	26	Q9ULI3
RTAPPRRTASPEPPA	PRR25	346	Q96S07
RRTASPEPPAPGAPL	PRR25	351	Q96S07
TRGSLVPTRPVPPSP	DDX31	41	Q9H8H2
PPSSPRSRDAPAGSP	RGL3	556	Q3MIN7
PVSSIHPPGRPPAVR	DNM2	771	P50570
PHTRAPSPLGPTRDP	FAAP100	661	Q0VG06
LRDPHPAPPRTSQEP	ATXN7	411	O15265
TPLRPGFSRTPQPPA	CASKIN2	361	Q8WXE0
ATPPDPPRPKRRSHS	CASKIN2	786	Q8WXE0
VSQRPSPSGPPPRCS	INO80B	296	Q9C086
PATPAPEPSRAPASL	NOS3	31	P29474
SSGLPPSPVPSPRRF	PABIR2	131	Q7Z309
TTPRPHAPTPDRPGE	PRR35	81	P0CG20
PPVTGTSEAPAVPPR	OBSCN	6271	Q5VST9
SPLDASPRRPPGPTT	PLCB3	911	Q01970
PPTPRRPASVNGSPS	ITCH	261	Q96J02
PPTGERRFQPPESPS	NLGN4Y	81	Q8NFZ3
PSSSAPRSPESPAPR	OTOP1	31	Q7RTM1
AHPRSRSDPGPPVPR	ARHGAP33	1191	O14559
RPRAPEHPAPPATAV	FAM157B	181	P0CG42
SPAPRPVPGSPARDA	CROCC	1451	Q5TZA2
SKDPGPPRPHRPEAT	CABIN1	1991	Q9Y6J0
FPRPFATPPATPGSR	CACNA1C	2031	Q13936
FATPQAPRPTPSAPR	E2F1	66	Q01094
DPPEPGSPRISSLRP	CSF1	396	P09603
EAPRRRSPSPTPTPG	CENPA	11	P49450
EPGSHPSPAPRRSPA	FARP1	421	Q9Y4F1
PAPRLAVPASPRGSP	EPOP	6	A6NHQ4
VSPEPRRPAPAVSPG	CHAMP1	296	Q96JM3
TTSPDRPGPPTRPLV	FNDC3B	566	Q53EP0
PAPTPGSTRSTRPPA	COL27A1	491	Q8IZC6
ALTPARAPSPVPAPA	RALGDS	276	Q12967
SPPASPARPNHRSPL	MARVELD2	116	Q8N4S9
PSRDPSPVCGSLRPP	MAST3	936	O60307
VPGPSRSAPSSPAPR	DENND4B	726	O75064
TPSRHSPASRIPPPE	DENND4B	1066	O75064
SAPVHEPPSPRSPRA	FRAT1	241	Q92837
EPPSPRSPRAACSDP	FRAT1	246	Q92837
RPSRTPAPDPGSPRT	DNAJC30	126	Q96LL9
SDASSPSPPAPRPER	C1orf127	346	Q8N9H9
RPQSVSRPPSEPPLH	BICRA	806	Q9NZM4
PRTAAEPRSPGPVPH	CAPN3	11	P20807
PGSVPRPPISVSFPR	SLC45A1	426	Q9Y2W3
PAPRVRPPSPDGSTS	KIFC2	146	Q96AC6
QGIRPRPPPAAPTHS	CPNE5	561	Q9HCH3
RPPAPSPPSAAAGAR	SCRIB	6	C0HLS1
EPRTRRGPSPPASPT	PKN3	536	Q6P5Z2
PPAGPARSPDPESRR	SLC12A5	11	Q9H2X9
RPTSPPQDHRPTCPG	NUTM2D	641	Q5VT03
RPTSPPQDHRPTCPG	NUTM2F	591	A1L443
RPTSPPQDHRPTCPG	NUTM2G	576	Q5VZR2
PPVLTHRAPQPGPSR	RTEL1	1156	Q9NZ71
PDHSPRARSVAPLPP	RTKN	526	Q9BST9
GPETSSPAPVSPREP	RSPH4A	76	Q5TD94
RPPRARPASTSPSPG	SRRM3	461	A6NNA2
PPRHRRSPSVSSPEP	SRRM2	1721	Q9UQ35
VPPPRAAPAPTHVRS	VGF	491	O15240
PPPPRVPRSASTGAQ	SLC6A5	46	Q9Y345
PPARASPSGPQPRRS	TGFBR3L	301	H3BV60
APARRPPAPSGDTAP	PLEKHA4	251	Q9H4M7
SETPPPPRRAVLSPG	ITPKB	31	P27987
APRRPPTPGPDTSVS	PRR36	1076	Q9H6K5
LSPRPDSPQPRHGSP	PPP1R35	46	Q8TAP8
VHSDPPSPPPGRKRS	SPATA31E1	86	Q6ZUB1
PGTPDSRPPFLSRPA	PKN1	351	Q16512
RPAATRTAPPTPSPG	SSC5D	996	A1L4H1
AAPPAPPPEVTATAR	NUP160	6	Q12769
PRFGHPSSVRIPPPS	NPAP1	106	Q9NZP6
PTPPPVPRRGTHTTV	NCKIPSD	241	Q9NZQ3
RDAPRASSPPRHPPS	TRIOBP	1221	Q9H2D6
PTPRGSHSPRPREAP	RITA1	146	Q96K30
PPVPSSSGRLTPSPR	SHANK1	936	Q9Y566
RAHTSPAPAPRPTPR	ARAP1	66	Q96P48
AVPRPPSNPPARGTL	TRAF3IP2	386	O43734
VPTRRPPATATSPVP	CLEC14A	301	Q86T13
PRPARPPSPTEQEGA	ZNF513	246	Q8N8E2
PESPASAPLQPGRRP	ZFR2	571	Q9UPR6
SPREPGEPPLFSRPS	SPEG	526	Q15772
PVTSRPARARPPDSP	SPEG	2786	Q15772
PARARPPDSPTSLAP	SPEG	2791	Q15772
PPPPRRSFPSSHGLT	SRCIN1	1006	Q9C0H9
PSPPTRRAPVAPTEE	SHC2	466	P98077
RPSADAAPPPRAPSE	SOWAHA	176	Q2M3V2
REPPTSPGAAPSPLR	TBX2	331	Q13207
PSPSPGRAQEPAPRS	PRR19	106	A6NJB7
HQRPLPPSEGLSPRP	TNS4	211	Q8IZW8
PPRPHSASAARPDLP	PLCH2	1181	O75038
TPRAFPEPGSRVPPS	ARHGAP23	266	Q9P227
SVPPASPARAPPATE	SCARF2	811	Q96GP6
GPPLPPASPSATSRR	UBE4B	376	O95155
SPHPAPSRREPLAPL	SYT15B	6	X6R8R1
FPPRGPPRSSSSDPD	SUSD4	351	Q5VX71
PMRTPPRASPTGTPS	nan	106	Q9UF83
ALERTEPSPPPSAPR	TESK1	546	Q15569
DPATPRVSPAHSPPE	TLE3	256	Q04726
PPGSIVRPSAPPARS	YLPM1	1521	P49750
LRPGPAAAAAPRPPS	TMEM65	16	Q6PI78
PRLVPTGPTHREPSP	ZDHHC5	516	Q9C0B5
PETTARPTPGAAPVP	WFIKKN1	171	Q96NZ8
PAPTRTPATAPVPAR	XRCC1	276	P18887
SPPSLAPRGPARAFP	ZNRF3	486	Q9ULT6
STRDASAPREPLPPP	WNK2	1501	Q9Y3S1
PAVVPAPVSAPRPAS	nan	46	Q6ZS46
SPSPGPHARPELPER	PRR23C	236	Q6ZRP0
HGPEPDSPFRRSPPR	TRNP1	206	Q6NT89
DSPFRRSPPRGPASP	TRNP1	211	Q6NT89
DSRPETLHPGRPQPP	VTN	136	P04004
RAPSPAAPSRPGAPA	WWC2-AS2	26	Q96NR7
RATGNDLRPPPPSPS	USP36	701	Q9P275
RRASAPVPVPSPAAP	WNT2B	16	Q93097
AAPEAGPSAPSRRPP	TRIO	2381	O75962
PPGATSRPTTAPPRT	TMEM108	146	Q6UXF1
DAPGTPPRRPASPSA	UTF1	31	Q5T230
PRSEGPHLSPRPEEP	KMT2D	736	O14686
SRPPSRPQSRDPFAP	KMT2D	2451	O14686
LNRTHSPPPDAPRPE	GRIN2D	466	O15399